Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,clathrin adaptor activity (GO:0035615),0.810086372358073,1.92325560066786,0.0,0.47331784355956885,0.317,3/15,0.32%,DAB2;AP2A2;HIP1
prerank,low-density lipoprotein particle binding (GO:0030169),0.8095083116714412,1.8975301661459845,0.0017271157167530224,0.336407723521677,0.415,7/16,3.55%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,protein kinase C binding (GO:0005080),0.6470259036153443,1.8950629971959558,0.0,0.2327472040644161,0.421,11/43,7.67%,HDAC9;NELL1;PDLIM5;GRK5;HINT1;ADAM9;UGT1A7;UGT1A10;RACK1;HSPB1;PRKCB
prerank,lipoprotein particle binding (GO:0071813),0.7674198480930836,1.8836665968949864,0.001694915254237288,0.2073210389145219,0.468,7/20,3.55%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,phospholipase activity (GO:0004620),-0.4939150833109345,-1.8550383193510234,0.0,0.37678615630414725,0.27,14/67,6.27%,PLCL1;PNPLA7;ABHD12;PLCB2;MGLL;PLD4;ENPP2;PLCB4;SMPD4;PLA2G6;LYPLA2;LIPH;LPL;PITPNM3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7563328334581895,1.8272955416728147,0.006968641114982578,0.31352417488677226,0.685,7/18,5.98%,PDLIM5;RAB10;S100A11;TMOD3;STXBP6;PDLIM1;ANXA2
prerank,retinoic acid binding (GO:0001972),0.8186225947305211,1.8252226268954779,0.005434782608695652,0.26876760469343286,0.698,10/12,17.22%,UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1;CYP26C1;CYP26B1;RARA;NR2F2
prerank,retinoid binding (GO:0005501),0.7093614425191507,1.8019501320004292,0.011764705882352941,0.2958935043267907,0.79,13/22,18.29%,UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1;CYP26C1;CYP26B1;RARA;RBP4;NR2F2;RBP1;ABCA4
prerank,glucuronosyltransferase activity (GO:0015020),0.7133782484982296,1.7895942598103898,0.007054673721340388,0.2958236522247305,0.827,8/19,3.64%,EXT1;LARGE2;UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.5449737645713528,-1.785025867643743,0.002652519893899204,0.4383762010846329,0.508,8/35,3.40%,PLCL1;MPPED2;PLCB2;PLD4;PLCXD3;ENPP2;PLCB4;SMPD4
prerank,lysophospholipase activity (GO:0004622),-0.6323743866570581,-1.7816046668285452,0.002380952380952381,0.3074326605009114,0.526,6/20,5.00%,PNPLA7;ABHD12;MGLL;ENPP2;PLA2G6;LYPLA2
prerank,death receptor activity (GO:0005035),0.8008370888533303,1.7791678406815614,0.005597014925373134,0.2920749227475026,0.857,3/11,4.18%,TNFRSF25;TNFRSF1B;TNFRSF11A
prerank,glutamate receptor activity (GO:0008066),-0.6319068297727027,-1.7624008982120176,0.004796163069544364,0.289059159747069,0.603,6/19,3.80%,GRID2;GRM7;GRIA2;GRIK2;GRM3;GRIA4
prerank,monocarboxylic acid binding (GO:0033293),0.7107881774504801,1.7252088163059949,0.01517706576728499,0.43547197466338017,0.967,9/18,9.99%,NR1H4;UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1;CYP26C1;CYP26B1
prerank,mannose binding (GO:0005537),0.7703212779960824,1.7150041100291047,0.021352313167259787,0.432778223600297,0.977,4/12,8.45%,CLEC6A;CLN5;ACR;CLEC4D
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4599797782842601,1.7142765737014825,0.0,0.3988322187294301,0.978,68/254,17.73%,RBPJ;ETV1;TCF4;IRF4;MEF2A;ZBTB16;RREB1;TFEC;ESR1;TCF12;MEF2C;NR1H4;MITF;KLF6;HOXD8;RAX;ALX1;HOXA10;NR3C1;CLOCK;GRHL2;NFIC;SMAD4;NR4A1;FOSL2;KLF4;YY1;REL;SATB2;CEBPG;NR4A2;IRF2;KLF10;ATF6;FOXC2;ESRRB;MDM2;FOXJ3;MLXIP;STAT6;CREBRF;SP1;TFDP1;ELF1;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXO1;CREB1;NR1H2;STAT3;KLF5;MYC;MTF1;SMARCD1;NR2C2;ELK1;ZFP62;HOXB3;CREB3L1;NFATC3;GLIS2;RELA;MEF2B;MECOM;GMEB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.7089240096841039,1.7139974156613125,0.016728624535315983,0.36898029603618643,0.978,4/16,3.66%,CD38;BST1;RPS3;DNPH1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7461572460057662,-1.7096359882976768,0.0020408163265306124,0.3974886923648147,0.813,7/10,16.99%,GNAS;DLG4;SHANK1;IGSF11;SHANK2;SHISA7;SQSTM1
prerank,endonuclease activity (GO:0004519),0.5731896405270908,1.7056355080417716,0.0075528700906344415,0.3661647189993005,0.983,16/49,13.53%,ENDOG;ANG;RPS3;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;ZRANB3;LACTB2;ZC3H12A;ZC3H12D;PIWIL2
prerank,phosphatidylinositol binding (GO:0035091),0.514878394595044,1.6908714071279665,0.0028011204481792717,0.38712966323095316,0.991,14/91,3.78%,DENND1A;SNX2;HIP1;SNX9;WDFY3;FCHO2;SNX8;SESTD1;ANKFY1;SNX24;MTM1;DENND1B;PITPNA;SNX27
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7499767013118984,1.6882540578570995,0.017964071856287425,0.3716743035492947,0.993,4/11,9.28%,EGFR;MAP3K5;MAP3K1;MAP3K20
prerank,acylglycerol lipase activity (GO:0047372),-0.7053250714292808,-1.6876216482431758,0.0044943820224719105,0.41456828461486533,0.88,5/11,17.06%,ABHD12;MGLL;ABHD15;ABHD16A;FAAH
prerank,hyaluronic acid binding (GO:0005540),0.771833856623842,1.6788431737495995,0.023529411764705882,0.37684798166732325,0.997,2/10,2.35%,LYVE1;CD44
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7714080669875742,1.6673522097462814,0.0186219739292365,0.3918237244893952,0.998,4/10,15.09%,CYBB;NCF2;CYBA;NOX4
prerank,solute:proton symporter activity (GO:0015295),-0.621768436966657,-1.665009295720636,0.011990407673860911,0.43475325727401604,0.924,7/16,12.85%,SLC2A9;SLC36A1;SLC25A3;SLC11A2;SLC2A13;SLC17A5;CTNS
prerank,phosphatidylglycerol binding (GO:1901611),0.716332516266259,1.6585177134469091,0.02010968921389397,0.3980172775387284,0.998,3/13,4.51%,PLTP;PITPNA;GSDME
prerank,voltage-gated chloride channel activity (GO:0005247),0.770065583922867,1.6580958783053232,0.03137254901960784,0.37948551486217086,0.998,4/10,5.28%,CLCN5;ANO6;CLCNKB;ANO1
prerank,ribonuclease activity (GO:0004540),0.539322931494349,1.6523129512519623,0.012030075187969926,0.37696851078460347,0.998,20/56,15.22%,ENDOG;ANG;RNASE4;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;RNASE6;LACTB2;ZC3H12A;EXOSC8;DIS3L2;ZC3H12D;PIWIL2;EXOSC1;SAMHD1
prerank,retinoid X receptor binding (GO:0046965),0.7387838908421013,1.6468992815450705,0.030357142857142857,0.37463587392186765,0.998,5/11,8.46%,RARG;ARID5A;NR4A2;NRIP1;NCOA6
prerank,chemokine activity (GO:0008009),0.5895071704212375,1.6387567964184493,0.025356576862123614,0.380244473136294,0.998,8/31,17.31%,PF4;CCL8;CCL19;CXCL16;CCL24;CKLF;CCL5;CCL25
prerank,cell adhesion mediator activity (GO:0098631),-0.540320492121998,-1.6300589416241298,0.01707317073170732,0.5219626904295777,0.967,8/24,8.31%,SIRPA;LRRC4C;PALLD;CNTN4;BSG;CNTN6;CNTN2;NTNG1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6886909869248087,-1.6273301448212114,0.022357723577235773,0.4745481321461879,0.967,4/10,11.72%,CACNB2;CACNB4;CACNA1D;CACNA1C
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5951021610685377,-1.6177299650065127,0.021844660194174758,0.46653165012714054,0.977,6/17,10.88%,PTK2B;GRIA2;GRIK2;GRIA4;GRIN3A;GRIN2A
prerank,voltage-gated cation channel activity (GO:0022843),-0.40414774428552125,-1.6071928001844757,0.007905138339920948,0.46110193953304734,0.982,21/97,14.04%,KCNMA1;CACNB2;KCND2;KCNH7;PTK2B;CACNB4;KCNQ3;CACNA2D3;CACNA2D1;GRIN3A;CACNA1D;KCNQ5;CACNA1E;KCNA1;KCNA2;CACNG7;GRIN2A;CACNA1C;CACNG8;KCNS3;HVCN1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.6012670597480034,-1.6055629386894068,0.01834862385321101,0.4281974541881381,0.983,4/16,8.80%,NAV2;HELQ;BLM;RECQL5
prerank,voltage-gated calcium channel activity (GO:0005245),-0.48560834178200474,-1.60213226124637,0.024793388429752067,0.40648633303733556,0.984,13/37,19.51%,CACNB2;CACNB4;CACNA2D3;CACNA2D1;CACNA1D;CACNA1E;CACNG7;CACNA1C;CACNG8;CACNG4;NCS1;ITGAV;CACNG2
prerank,triglyceride lipase activity (GO:0004806),-0.5606583367054292,-1.5991123134176572,0.023094688221709007,0.38795073825115,0.984,3/20,5.91%,DAGLB;LIPH;LPL
prerank,cation:chloride symporter activity (GO:0015377),-0.6770913780059837,-1.5962888700967164,0.029411764705882353,0.3704373785788759,0.985,7/10,25.15%,SLC12A2;SLC12A9;SLC12A6;SLC6A1;SLC12A4;SLC12A5;SLC12A1
prerank,endoribonuclease activity (GO:0004521),0.5777725570349335,1.5892107169500689,0.03870967741935484,0.5222550620612082,1.0,13/32,13.53%,ENDOG;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;LACTB2;ZC3H12A;ZC3H12D;PIWIL2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6206208986333431,-1.5868016761844332,0.03938730853391685,0.37607450662706177,0.989,7/14,24.81%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC17A6;SLC1A2;SLC25A13
prerank,CXCR chemokine receptor binding (GO:0045236),0.7176246383289093,1.585584073466693,0.04251386321626617,0.513334715787787,1.0,1/11,0.26%,PF4
prerank,amyloid-beta binding (GO:0001540),0.4897014322148203,1.5822595886978736,0.02032520325203252,0.5046491979528557,1.0,15/79,4.97%,MSR1;FCGR2B;APOE;ITM2B;C1QA;LDLR;ADRB2;LILRB1;LILRB3;CD36;CD74;TLR4;TLR2;TM2D1;INSR
prerank,rRNA binding (GO:0019843),0.5442168446653581,1.5815145965583923,0.03354632587859425,0.4889647144210423,1.0,14/42,9.26%,RPL23;ANG;RPS3;RPS13;ERAL1;RPL12;NOP53;RPLP0;RPL5;RPS14;RPS9;MDM2;RPS5;MRPS11
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5748874041687766,-1.5587925022210634,0.030660377358490566,0.41474080574870426,0.998,7/16,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5748874041687766,-1.5587925022210634,0.030660377358490566,0.41474080574870426,0.998,7/16,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,cGMP binding (GO:0030553),0.6975205696547523,1.5486633211942846,0.05523809523809524,0.5849764287027168,1.0,4/11,10.59%,CNGA3;RAPGEF2;PDE2A;PDE5A
prerank,CCR chemokine receptor binding (GO:0048020),0.5784221984751896,1.540309635124603,0.03511705685618729,0.5955927438692722,1.0,7/28,8.22%,CCL8;MSMP;NES;CCL19;CCRL2;CCR2;CCL24
prerank,gated channel activity (GO:0022836),-0.586733255498253,-1.5360329874738163,0.03225806451612903,0.46477193456198385,0.999,10/14,32.37%,PIEZO1;TMC7;PACC1;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,cytokine activity (GO:0005125),0.44380534689771245,1.53172717656299,0.007731958762886598,0.6073267729585625,1.0,16/131,8.22%,PF4;IL16;IL15;TSLP;KITLG;BMP2;CCL8;WNT2;GDF3;CCL19;GDF10;FAM3C;TNF;WNT6;CXCL16;CCL24
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.588312450007285,-1.5279161511244588,0.06086956521739131,0.4653930106438039,1.0,8/15,27.74%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC17A6;SLC1A2;SLC25A13;SLC1A4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5214708727358697,-1.5277880131050632,0.022727272727272728,0.4437243562336386,1.0,8/22,12.46%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V0B;ATP6V0D2;ATP6V0C;ATP2C1
prerank,sequence-specific DNA binding (GO:0043565),0.39038662955671255,1.5172071383802843,0.0,0.6420895353113479,1.0,131/590,18.57%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;MEF2A;AHR;FOXN2;TFEC;KMT2A;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;DMRTA2;NFIC;ARID5A;SMAD4;SMG6;ELF2;THRB;IRX2;MBNL2;CBFB;NR4A1;TCF7;BCL2;KLF3;ZNF148;KLF4;YY1;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;TET3;FOXC2;ESRRB;OLIG2;HIVEP1;FOXJ3;ATF7;NFATC2;NR2F1;RFX2;ZNF296;SP1;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;FOXO3;FOXK1;TERF2IP;SP3;NFIX;FOXO1;CREB1;KLF13;RARA;MBD1;KLF5;JUND;TERF1;USF1;PRMT1;MTF1;HDAC4;KDM2A;NR2C2;RUNX3;ELK1;E2F8;KDM1A;CREB3L1;ZGPAT;ZNF177;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;LHX1;ZBTB7A;NR2F2;XBP1;MEF2B;NR6A1;SP8;GMEB1;ZNF32;GZF1;BATF;HSF5;ZBTB12;MAFB;ATF2;RFX3;LONP1;ZBTB14
prerank,lipase activity (GO:0016298),-0.44318876081683045,-1.510174154745495,0.022222222222222223,0.4815221682837967,1.0,11/43,18.59%,ABHD12;MGLL;DAGLB;LIPH;LPL;PITPNM3;ABHD15;DDHD1;ABHD16A;FAAH;SMPD2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6055707244261362,-1.5097536664945304,0.04434589800443459,0.462071603771462,1.0,9/12,32.37%,PIEZO1;TMC7;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5285919136566324,1.5075904972735923,0.048558421851289835,0.6596745203432886,1.0,4/38,5.98%,SERPINB8;APP;SERPINB2;ANXA2
prerank,voltage-gated anion channel activity (GO:0008308),0.6471659588441866,1.505618924198889,0.0670391061452514,0.6476559899195077,1.0,4/15,5.28%,CLCN5;ANO6;CLCNKB;ANO1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6507985712735137,1.5053818874200737,0.07468123861566485,0.6294414006111816,1.0,6/14,22.10%,CYBB;NCF2;CYBA;NOX4;AIFM1;KMO
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.45548329358015816,1.5009886084149378,0.023383768913342505,0.6275512849083776,1.0,15/100,7.13%,IQGAP2;DENND1A;HIP1;IQGAP1;ARHGAP9;SESTD1;ANKFY1;ARAP1;SNX24;FCHSD2;DENND1B;SNX27;SNX3;KIF16B;WIPI1
prerank,epidermal growth factor receptor binding (GO:0005154),0.5689005130314704,1.4988215882834792,0.06734006734006734,0.618377375504478,1.0,3/25,1.92%,SNX2;HIP1;FER
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.42603686171688826,-1.495420138380439,0.02932551319648094,0.48853672074829163,1.0,10/46,11.80%,HEXB;LARGE1;MGAT4C;GCNT2;MGAT5;B3GALT1;B3GALT5;MGAT4B;POMGNT1;B3GALT2
prerank,microtubule binding (GO:0008017),-0.3327709699625247,-1.49070642206884,0.0,0.4845221539638606,1.0,86/222,25.01%,NAV3;DST;MAP4K4;MAP2;KIF21B;CCDC88B;DNM3;CLASP2;EML3;NEFM;CAMSAP1;MAP1B;CCDC66;FGF13;KIF1A;MTCL1;NEFH;KIF5A;CLIP2;MACF1;KIF6;KIF5C;CRIPT;MAPT;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;CENPE;MAP6;ARHGEF2;MAPRE3;IRAG2;KRIT1;CEP44;TPPP;KIF1C;MTUS1;KIF3A;EML6;TOGARAM1;HAUS7;NUMA1;CKAP5;EML1;KIF15;TUBGCP3;MAPRE1;EML2;SGIP1;MAP1LC3A;KIF3B;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;NUSAP1;KIF2A;GOLGA2;EML5;SKA2;FSD1;TUBGCP6;KIFC1;GAPDH;CLIP4;ARL3;REEP2;TOGARAM2;HDAC6;KATNB1;MAP9;FNTA;CETN3;REEP4;BIRC5;GAS2L3;DCTN1;KIF14;HOOK2;S100A9;HAUS6;HDGFL3
prerank,SH2 domain binding (GO:0042169),-0.47193467002859363,-1.4906188181606268,0.03430079155672823,0.466244999627839,1.0,6/31,4.20%,PAG1;ARHGAP5;BLNK;JAK2;SRC;LAT2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6209002017508737,-1.4889763747440847,0.04842105263157895,0.4536922439665526,1.0,6/12,18.86%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ENG
prerank,kinase inhibitor activity (GO:0019210),0.53003599073522,1.4874447251990908,0.05672609400324149,0.6420503158224842,1.0,16/33,23.00%,LRP6;SH3BP5;GMFG;DNAJC3;SMCR8;SH3BP5L;PARVA;GMFB;TRIB1;SNCA;DUS2;CDKN1C;CDKN1B;NPM1;QARS1;NCK1
prerank,BMP binding (GO:0036122),-0.6318254173866427,-1.483563796155798,0.05793991416309013,0.45438369771725606,1.0,4/11,32.70%,ENG;GREM1;GREM2;BMPR2
prerank,carboxy-lyase activity (GO:0016831),-0.49458260228914125,-1.4747823476457038,0.05172413793103448,0.46594983747578045,1.0,9/23,12.78%,PPCDC;AZIN1;BCKDHA;UMPS;GGCX;CSAD;UXS1;PCK2;DDC
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.643649062940604,-1.4725006900135373,0.04525862068965517,0.4575950553942858,1.0,6/10,27.23%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4116294204417936,1.470191877400578,0.015776699029126214,0.690289501837664,1.0,42/181,15.93%,RBPJ;TCF7L2;MDFIC;MEF2A;RBBP8;NCOA3;NR1H4;NCOA2;PIAS1;BCL10;HEY2;SPI1;GSK3B;NCOA7;RB1;ACTB;TRIM32;PIAS2;DMAP1;HSPB1;KLF4;MIER1;FIZ1;NRIP1;NCOR1;MAPK14;SPEN;MIER3;SP1;JUP;CREBBP;PSMA6;BUD31;BCAS3;CREB1;STAT3;EP300;SNW1;HDAC4;ARID1A;ELK1;KDM1A
prerank,transferrin receptor binding (GO:1990459),0.6856859646391364,1.4687197272847825,0.07662835249042145,0.678407197367246,1.0,2/10,7.63%,SNX2;HFE
prerank,RNA cap binding (GO:0000339),-0.5595099509702182,-1.4650719582304537,0.07021276595744681,0.4652394111827086,1.0,12/16,37.18%,EIF4A1;CYFIP2;DCPS;NCBP1;EIF4E;LARP1;SNUPN;NCBP3;EIF4E2;EIF3D;GEMIN5;NCBP2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4753643556476719,-1.4610383954872292,0.043243243243243246,0.4616018587276941,1.0,9/29,16.82%,GRID2;GRIA2;GRIK2;GABRB3;GRIA4;GABRB1;GABRA2;GABRG2;GLRA3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5915818990689977,1.4537950903610741,0.07936507936507936,0.7191448537347478,1.0,4/18,4.77%,TNFAIP8;GAS6;RPS6KA3;BIRC3
prerank,1-phosphatidylinositol binding (GO:0005545),0.6145330808057006,1.4504948418668184,0.0954861111111111,0.714556337298809,1.0,3/15,1.61%,SNX9;WDFY3;SESTD1
prerank,protein kinase binding (GO:0019901),0.3767975051249893,1.450243969295209,0.0031545741324921135,0.6986374407715892,1.0,100/479,14.23%,BANK1;HDAC9;AP2A2;NELL1;PDLIM5;NEDD9;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;GRK5;DNAJC3;HINT1;ITGB1;RPS3;IRAK3;OXSR1;CASS4;EEF1A1;MYH6;PRKAG3;CDC42;GDF3;ADAM9;MAP3K1;AXIN1;CRK;UGT1A7;UGT1A10;RHOA;UTRN;RGCC;PRKN;BCL10;DUSP1;NR3C1;GCH1;DOK7;GSK3B;PGAM1;RACK1;GPRC5B;PAK2;PTPRK;MAPKAPK2;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;DUSP22;DUSP2;PRKCB;IFNAR2;RHOBTB1;TRIM68;MAPK8IP2;VRK1;MSN;TRIM27;RCC2;MAPK4;SMCR8;RPS7;ATF7;SH2B3;CCND2;CACUL1;ACSL3;RPS6;MAML1;CALM1;SPRED2;SHC1;IL15RA;FOXO3;KCNQ1;STK38;TRIB2;MAP3K11;CDKN2C;NOD2;EXOC2;RBBP6;RND3;CTBP2;CNTLN;RARA;FAM83B;IBTK;STAT3;CAVIN3;ITGB2;RHOC
prerank,GDP binding (GO:0019003),0.4665360363548159,1.446139128345155,0.04457652303120357,0.6974683656681173,1.0,12/63,8.92%,RAP1B;RAB31;RAP2B;NRAS;KRAS;GNAI3;RAB8B;RAB10;RAP1A;GEM;RAB7A;RAB14
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6066895101338946,-1.4451888581533894,0.061052631578947365,0.4919675387507697,1.0,4/10,7.43%,SLC24A3;SLC24A2;SLC8A1;SLC24A4
prerank,chemokine receptor binding (GO:0042379),0.5083601680551543,1.4434119147359328,0.08253968253968254,0.6921295532629853,1.0,6/35,8.22%,PF4;CCL8;CCL19;CCRL2;CXCL16;CCL24
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5203120757179387,1.4433689089244321,0.07603305785123966,0.6769444824095762,1.0,6/34,5.87%,IQGAP2;IQGAP1;ARHGAP9;ARAP1;FCHSD2;KIF16B
prerank,double-stranded DNA binding (GO:0003690),0.37073246680446,1.4407135748933215,0.0010427528675703858,0.671242256223043,1.0,114/531,18.05%,MAF;ETV1;EGFR;KLF2;TCF4;RBMS1;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RBBP8;RARG;RPS3;TCF12;MEF2C;CEBPB;DDX60;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;MND1;NR3C1;HEY2;CLOCK;DMRTA2;NFIC;ELF2;THRB;MBNL2;NR4A1;TCF7;KLF3;KLF4;YY1;DDX11;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;FOXC2;ESRRB;OLIG2;HIVEP1;FOXJ3;ATF7;NFATC2;NR2F1;PURA;POLG2;RFX2;ZNF296;SP1;PCID2;ELF1;ETS2;SREBF2;BCL11B;MYBL2;XPA;FOXO3;FOXK1;SP3;NFIX;CREB1;KLF13;RARA;KIN;MBD1;KLF5;JUND;TERF1;USF1;RAD51B;MTF1;NR2C2;RUNX3;ELK1;FBH1;E2F8;CREB3L1;ZNF177;TBX2;NFATC3;ARNT;GLIS2;NR5A2;LHX1;ZBTB7A;XBP1;MEF2B;DMC1;NR6A1;SP8;GMEB1;ZNF32;BATF;HSF5;ZBTB12;APTX
prerank,phospholipase C activity (GO:0004629),-0.46502523673133067,-1.4357373089687675,0.0639386189258312,0.5061465617773471,1.0,8/25,11.24%,PLCL1;PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5855599173468388,-1.435467793973677,0.07430997876857749,0.49266120814085435,1.0,4/12,8.69%,ITGB3;VEGFB;ITGA5;CADM4
prerank,PDZ domain binding (GO:0030165),-0.3872120581197291,-1.434216537108092,0.04318936877076412,0.4826853789589225,1.0,14/61,7.74%,CADM1;F11R;GRID2;DOCK4;NLGN1;DLG4;GNG12;PLEKHA1;TBC1D10A;CIT;SYNJ2;CRIPT;SDC2;TGFBR3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.49968852798948504,1.4322150348191358,0.07906976744186046,0.6882126337953358,1.0,7/38,7.13%,DENND1A;HIP1;SESTD1;SNX27;SNX3;KIF16B;WIPI1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.52251608170682,-1.4286712108944857,0.06775700934579439,0.48732091302806213,1.0,7/18,18.86%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ACVR1B;ENG
prerank,symporter activity (GO:0015293),0.6545177499934123,1.4250733488658023,0.128060263653484,0.7010124122416341,1.0,4/10,17.21%,SLC28A2;SLC4A4;MFSD2A;SLC5A6
prerank,ligand-gated anion channel activity (GO:0099095),-0.5212031766471014,-1.4232785729194781,0.07142857142857142,0.48975117872992074,1.0,12/17,29.49%,GABRB3;GABRB1;GLRB;GABRA2;GLRA1;GABRG2;GLRA3;CFTR;GLRA2;GABRA4;GABRG3;GABRE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6572740157907053,1.4218021458195564,0.12770137524557956,0.6984411896277058,1.0,3/10,15.98%,SLC10A6;SLC10A3;SLC6A11
prerank,protein kinase activator activity (GO:0030295),0.45875019969549974,1.4215962527122872,0.06047819971870605,0.685313385143956,1.0,16/60,10.64%,IQGAP1;PRKAG2;GAS6;ABI1;RPLP1;RGCC;GHRL;GPRC5B;INCENP;PAK2;STK3;WNK1;FAM20A;PARP16;MARK2;CALM1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.5797575060925383,-1.4178867430367015,0.08333333333333333,0.4943394027306807,1.0,6/13,22.05%,LPIN2;PLPP3;PLPPR1;PLPP4;PLPP2;PLPP5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.40859197175745915,1.4159479549598333,0.035175879396984924,0.6925082612280761,1.0,28/147,10.09%,ITSN1;VAV3;DENND1A;FGD4;RASGRP4;SBF2;FGD6;RGL1;DOCK2;SH3BP5;RIN2;DOCK1;DENND1B;RAPGEF2;RIC1;RAP1A;DOCK11;GAPVD1;MYCBP2;NUCB2;NGEF;FNIP1;DENND4C;DENND5A;SMCR8;DENND2C;EEF1D;CYTH1
prerank,tubulin binding (GO:0015631),-0.3071849961880137,-1.4144553168662393,0.0,0.4919698913116857,1.0,108/295,25.01%,NAV3;DST;MAP4K4;MAP2;UNC5C;KIF21B;CCDC88B;DNM3;TRAPPC14;CLASP2;PAK1;TTLL11;TBCD;EML3;NEFM;CAMSAP1;MAP1B;CCDC66;IFT81;DIP2B;FGF13;KIF1A;ALDOA;MTCL1;NEFH;KIF5A;CLIP2;KIF6;KIF5C;TTLL7;CRIPT;MAPT;APPL1;NCALD;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;CENPE;MAP6;ARHGEF2;BRCA1;MAPRE3;IRAG2;STMN3;VBP1;KRIT1;CEP44;BRCA2;TPPP;KIF1C;STMN4;MTUS1;KIF3A;EML6;TOGARAM1;NUMA1;TTLL1;CKAP5;EML1;KIF15;TUBGCP3;GPAA1;EML2;SGIP1;MAP1LC3A;KIF3B;GABARAPL1;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;NUSAP1;KIF2A;GOLGA2;EML5;SKA2;FSD1;B9D2;EMD;BBS4;TUBGCP6;KIFC1;SETD2;GAPDH;PRUNE1;ARL3;REEP2;TOGARAM2;HDAC6;KATNB1;BRSK1;MAP9;FNTA;RITA1;CETN3;REEP4;BIRC5;GAS2L3;DCTN1;KIF14;HOOK2;S100A9;HAUS6;HDGFL3
prerank,hexosaminidase activity (GO:0015929),-0.5639551193898685,-1.411150171194586,0.09070294784580499,0.4895897308395889,1.0,3/12,10.80%,HEXB;HEXD;HYAL1
prerank,muscle alpha-actinin binding (GO:0051371),0.6018030078488911,1.4105152977651325,0.09706959706959707,0.6991255099462401,1.0,6/15,17.63%,PDLIM5;NRAP;PDLIM1;PKD2L1;PKD2;PDLIM2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6424790294172609,1.4101868658862677,0.10973451327433628,0.6872076159961243,1.0,1/11,0.54%,PADI4
prerank,phosphatidic acid binding (GO:0070300),0.5593637173499324,1.4074025666083467,0.10304054054054054,0.6846230394064104,1.0,5/19,11.87%,PLTP;SESTD1;RAPGEF2;PACSIN2;GRAMD1B
prerank,GTPase activator activity (GO:0005096),0.3773585993680319,1.4063218377379259,0.012235817575083427,0.6759626017507185,1.0,46/313,6.86%,ITSN1;ARHGAP15;STARD8;VAV3;IQGAP2;DENND1A;NRP1;FGD4;RASGRP4;SBF2;GNAQ;FGD6;IQGAP1;ARHGAP9;RGL1;TBC1D5;TBC1D4;DOCK2;SH3BP5;OPHN1;ARAP1;EVI5;RIN2;RASA1;USP6NL;DOCK1;ARHGAP10;DENND1B;ARHGAP18;ARHGEF10L;ARHGAP31;RAPGEF2;RIC1;NPRL3;RAP1A;DOCK11;OCRL;TBC1D14;RGS8;ARHGAP29;GAPVD1;MYCBP2;NUCB2;NGEF;STXBP5;TBC1D2B
prerank,histone deacetylase binding (GO:0042826),0.4260669758043882,1.4048475713774013,0.06205923836389281,0.6690434335321059,1.0,28/88,17.38%,HDAC9;MEF2A;MEF2C;HOXA10;PRKN;HEY2;SPI1;PKN2;BRMS1L;MIER1;SATB2;GMNN;NCOR1;LCOR;MIER3;SP1;ZMYND15;YWHAE;BCOR;KPNA2;USF1;HDAC4;SFPQ;HSP90AB1;TOP2B;RELA;NACC1;MEF2B
prerank,retinoic acid receptor binding (GO:0042974),0.5668967538886752,1.40364685448352,0.12347826086956522,0.6614234270301761,1.0,6/17,9.48%,RARG;ARID5A;NR4A2;NRIP1;NCOA6;ASXL1
prerank,acid-thiol ligase activity (GO:0016878),-0.5571197563472555,-1.399721926879582,0.091324200913242,0.5128067473979848,1.0,7/13,33.80%,AASDH;ACSS1;ACSS3;SLC27A2;ACSF3;ACSS2;AACS
prerank,single-stranded DNA helicase activity (GO:0017116),-0.5025087862605832,-1.3990842557035141,0.08530805687203792,0.5023735175000799,1.0,14/19,39.41%,DNA2;HELQ;RFC2;MCM6;DHX9;RAD51;CHTF18;MCM2;MCM7;POLQ;DSCC1;PIF1;MCM5;RFC5
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5287463201381501,1.3960629934208237,0.1008130081300813,0.6752771314676806,1.0,10/29,16.14%,PTPRJ;DUSP1;GCH1;MAPKAPK2;DUSP2;MAPK14;ATF7;PRMT1;DUSP7;MAPK7
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5362047817633926,1.3903556309291079,0.10234899328859061,0.6833571947847705,1.0,5/23,7.13%,HIP1;SESTD1;SNX3;KIF16B;WIPI1
prerank,growth factor receptor binding (GO:0070851),0.4196826089785596,1.3901732561348972,0.05053191489361702,0.6726524588052137,1.0,15/95,9.45%,SNX2;HIP1;PTPRJ;FER;TSLP;FGF23;ERN1;PIBF1;FRS2;PDGFRA;SDCBP;PSEN1;FYN;IL6R;PDGFC
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.597470167301648,-1.3844878598057553,0.11134020618556702,0.5353958132598516,1.0,3/10,6.23%,CYLD;OTUD5;STAMBP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5718612572364065,1.384228811577068,0.1223021582733813,0.6809755467036921,1.0,5/15,11.96%,CCR1;CMKLR1;CCRL2;CCR2;GPR17
prerank,SH3 domain binding (GO:0017124),0.4434468585152114,1.3838607801735134,0.07625899280575539,0.671348552900091,1.0,11/62,4.82%,AFAP1L1;PTPN12;ABI1;PTPN22;WASF2;SYNJ1;ADAM9;CBL;CRK;PRKN;WIPF1
prerank,cadherin binding (GO:0045296),0.36945492970881155,1.380234116761177,0.011160714285714286,0.67245842518838,1.0,87/315,16.20%,AHNAK;SNX2;PDLIM5;EGFR;PTPRJ;EHD4;CTNNA1;IQGAP1;SNX9;EPS15;ITGB1;ABI1;WASF2;EIF3E;SPTBN1;RPL23A;ARHGAP18;SWAP70;CD46;CBL;TMPO;RAB10;S100A11;EHD1;GOLGA3;RPL24;SND1;TMOD3;RACK1;PKN2;PAK2;TXNDC9;STXBP6;PDLIM1;CTNND1;STK24;ANXA2;SFN;GAPVD1;CNN2;BAG3;EPN2;FLNB;PSEN1;RPL14;VASN;DCHS1;VCL;LRRFIP1;RPL34;CDH12;RAB1A;SERBP1;EEF1D;RPL6;RTN4;AHSA1;MARK2;PACSIN2;DDX6;CHMP5;PPP1CA;JUP;PLCB3;CEMIP2;YWHAE;RPL15;NIBAN2;STK38;SNX5;CAST;VAPA;DIAPH3;GLOD4;CAPZA1;TAGLN2;ADD1;RARS1;PARVA;EIF5;BZW2;FXYD5;UBAP2;TRIM25;IDH1;HSP90AB1;HCFC1
prerank,mannosyltransferase activity (GO:0000030),-0.48340594369382855,-1.3729281250174055,0.06698564593301436,0.559888586351828,1.0,11/21,23.29%,DPY19L4;TMTC4;ALG1;DPY19L1;TMTC2;ALG12;ALG3;DPY19L3;ALG8;TMTC1;PIGB
prerank,protein kinase inhibitor activity (GO:0004860),0.4638631564283112,1.3711443202418288,0.09399075500770417,0.6912280245707714,1.0,20/42,23.00%,SPRED1;SH3BP5;GMFG;DNAJC3;RACK1;SMCR8;SPRED2;SH3BP5L;IBTK;PARVA;GMFB;SPRY2;TRIB1;SNCA;DUS2;CDKN1C;CDKN1B;NPM1;QARS1;NCK1
prerank,endodeoxyribonuclease activity (GO:0004520),0.5321463226069817,1.3708363689833492,0.13394495412844037,0.6816168119029328,1.0,5/20,10.47%,ENDOG;RBBP8;RPS3;DCLRE1C;ZRANB3
prerank,neuropeptide binding (GO:0042923),-0.5050320622932724,-1.3698914449830706,0.10501193317422435,0.5575507999729967,1.0,10/18,47.84%,SORL1;GPR149;OPRL1;OPRD1;OPRK1;MC4R;SSTR2;OPRM1;GPR37;NMUR1
prerank,RNA methyltransferase activity (GO:0008173),-0.49858031035497047,-1.366297072710472,0.11316397228637413,0.5576690591405957,1.0,9/19,21.66%,TRDMT1;FTSJ3;TRMT12;MEPCE;TGS1;BCDIN3D;TRMT9B;MRM2;METTL3
prerank,actin binding (GO:0003779),0.3865008810899881,1.3611397016861388,0.038461538461538464,0.7031608935625752,1.0,31/170,14.55%,EPS8;IQGAP2;MTSS1;PDLIM5;FLII;PHACTR2;ANG;ITGB1;TMOD1;NRAP;SYNE2;UTRN;PRKN;LCP1;SSH2;PDLIM1;CXCR4;FLNB;VCL;FHDC1;SYNPO;FHL3;NOD2;PARVB;SLC6A2;CORO7;SPEF1;CAPZA1;ADD1;SPTBN5;PARVA
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5683117147892257,1.3599448319002778,0.1349911190053286,0.6971469150714102,1.0,2/16,1.41%,ALOX5;ALOX15
prerank,chemokine binding (GO:0019956),0.49036137289640697,1.3580671430218196,0.12271973466003316,0.6931506266372174,1.0,6/30,7.58%,ITGA4;CCR1;ITGB1;CCRL2;CXCR4;CCR2
prerank,filamin binding (GO:0031005),-0.5631733315434286,-1.351572225283297,0.11300639658848614,0.5927826158704442,1.0,3/11,6.54%,FBLIM1;TMEM67;NEBL
prerank,DNA-binding transcription factor binding (GO:0140297),0.37315479803489227,1.351418770498577,0.03952095808383234,0.7048603519507737,1.0,27/189,11.73%,RBPJ;HDAC9;TCF7L2;MEF2A;TLE4;RBBP8;TCF12;MEF2C;PIAS1;HEY2;SPI1;GSK3B;RB1;PIAS2;BCL2;DMAP1;HSPB1;KLF4;MIER1;FIZ1;NCOR1;PURA;SPEN;MIER3;SP1;CREBBP;CRTC3
prerank,Wnt-activated receptor activity (GO:0042813),-0.518941846555754,-1.3507807139112444,0.12045454545454545,0.5832622659541099,1.0,10/15,41.21%,LRP5;TSPAN12;FZD4;FZD6;FZD2;FZD5;PKD1;FZD8;FZD1;FZD10
prerank,cytokine receptor binding (GO:0005126),0.4089610695804613,1.3488994938938872,0.08891928864569083,0.7031592001782828,1.0,22/83,17.65%,LIFR;SPRED1;TSLP;KITLG;PIBF1;CCL19;TGFBRAP1;SYK;CCRL2;SDCBP;USP15;IL6R;SH2B3;PXDN;SPRED2;JAK1;CRLF2;IL13RA1;ERAP1;CCL5;CCL25;IL6
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3465016225449906,1.348643657779284,0.00823045267489712,0.6941095160150422,1.0,127/597,18.00%,MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RARG;TCF12;MEF2C;CEBPB;OSR1;ORC5;KLF6;ARID4B;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;DMRTA2;SPI1;NFIC;ARID5A;SMAD4;ELF2;THRB;MBNL2;NR4A1;ORC2;TCF7;MCM9;ZNF568;TNF;KLF3;KLF4;YY1;DDX11;TBL1XR1;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;NCOR1;ATF6;FOXC2;ESRRB;ASH2L;OLIG2;HIVEP1;TBL1X;FOXJ3;ATF7;NFATC2;BEND3;NR2F1;RFX2;ZNF296;SP1;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;HINFP;FOXO3;DHX33;FOXK1;SP3;NFIX;CREB1;KLF13;PSPC1;RARA;KAT7;STAT3;KLF5;BCOR;JUND;USF1;MTF1;HDAC4;NR2C2;SFPQ;RUNX3;ELK1;E2F8;MCM8;CREB3L1;PER1;ZNF177;TBX2;NFATC3;ARNT;GLIS2;NR5A2;RELA;LHX1;ZBTB7A;XBP1;MEF2B;ARID4A;NR6A1;SP8;GMEB1;ZNF32;BATF;HSF5;ZBTB12
prerank,ligand-gated ion channel activity (GO:0015276),-0.4297912047495382,-1.34808294248078,0.09510869565217392,0.5806647314296002,1.0,6/30,5.51%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,GTPase inhibitor activity (GO:0005095),0.5839826734597925,1.3471209344146997,0.15037593984962405,0.6897662238099502,1.0,2/13,0.99%,IQGAP2;IQGAP1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5105995732515712,1.3430333892563555,0.13747954173486088,0.6937672501489571,1.0,4/25,5.87%,HIP1;SESTD1;FCHSD2;KIF16B
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.47205434325864076,1.3403224383589796,0.09748427672955975,0.6932065971609667,1.0,10/35,11.03%,PEAK1;LYN;FER;FRK;SYK;ZAP70;FYN;DYRK1A;STYK1;SLA
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5795196851749917,-1.3343638160496851,0.14489795918367346,0.6111916356812533,1.0,3/10,1.96%,DPP10;NAALAD2;DPP6
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5430506600423387,-1.333548253467238,0.1347517730496454,0.6017470794018421,1.0,5/11,19.41%,CASP7;CFLAR;CASP6;PYCARD;CASP12
prerank,channel activity (GO:0015267),0.4543327772961483,1.3326886306278973,0.125948406676783,0.7077601253006445,1.0,4/41,8.44%,MCUB;SLC14A1;BCL2;TRPV3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5674589508094632,-1.3323596378944174,0.14988290398126464,0.5938698245252024,1.0,6/11,28.17%,SRRM2;EHMT2;TAF9;LEF1;THAP7;MBD2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5658771544781548,1.3303718770674426,0.13931297709923665,0.7060135776540459,1.0,8/14,23.82%,MTM1;SYNJ1;MTMR3;PTEN;MTMR1;MTMR6;MTMR12;MTMR11
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5626738369203961,-1.3285683995769209,0.14317180616740088,0.5950828976549627,1.0,7/11,18.41%,TRPC4;TRPC1;TRPC3;ITPR2;TRPC5;CYTH2;RPH3A
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.615505891507066,1.328470332180499,0.17261904761904762,0.7032963643059645,1.0,2/10,7.27%,DSE;FUOM
prerank,ligand-gated channel activity (GO:0022834),-0.42979464856325944,-1.3255819962980055,0.10364145658263306,0.5934099654480401,1.0,6/29,5.51%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,semaphorin receptor activity (GO:0017154),0.5985269425273212,1.325293068199435,0.15140186915887852,0.7055259326824439,1.0,3/11,6.52%,NRP1;PLXNC1;PLXNA4
prerank,chemokine receptor activity (GO:0004950),0.5044730644093447,1.324525254954817,0.14770797962648557,0.6989100702838493,1.0,5/24,7.58%,CCR1;CMKLR1;CCRL2;CXCR4;CCR2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.48192274445543726,-1.3239612865751318,0.13908872901678657,0.5881183837877283,1.0,9/18,23.12%,TGFBR1;SMAD7;FERMT2;TGFBR3;TGFBR2;ENG;TGFB2;TGFB1;BAMBI
prerank,cytokine receptor activity (GO:0004896),0.41055825530996837,1.320960320827842,0.10690121786197564,0.7020310887300113,1.0,20/83,11.96%,LIFR;CCR1;CMKLR1;IFNAR1;CD44;CD74;IL17RB;IL17RD;IL17RC;IL17RA;IL10RB;GFRA3;CCRL2;CCR2;IL20RB;IFNAR2;IL6R;IL1RL1;IL15RA;GPR17
prerank,metal ion:proton antiporter activity (GO:0051139),0.5616610037709849,1.320453823846444,0.15413533834586465,0.6951025794586935,1.0,4/13,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,potassium:proton antiporter activity (GO:0015386),0.597494312835332,1.3174652702619025,0.16565656565656567,0.6967150882067632,1.0,4/10,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5680784788188653,1.3165228988391944,0.17333333333333334,0.6912900656508767,1.0,4/12,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,double-stranded RNA binding (GO:0003725),0.41644122682692064,1.313910328717613,0.12907801418439716,0.6908722154259026,1.0,17/70,13.29%,TLR8;OAS2;MBNL1;CLTC;DDX60;PRKRA;RFTN1;VIM;RC3H1;DROSHA;STAU2;MSN;LRRFIP1;ILF3;EIF4B;DHX33;MRPL44
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6100043978744377,1.3124274933459825,0.19366852886405958,0.6873233177465291,1.0,1/10,0.19%,GDA
prerank,glutathione transferase activity (GO:0004364),0.5124416450436082,1.3121669988265545,0.15307820299500832,0.6802295166666684,1.0,4/23,8.98%,LTC4S;ALOX5AP;MGST3;MGST1
prerank,sodium:proton antiporter activity (GO:0015385),0.5774203989472352,1.3118841320294083,0.17913385826771652,0.6732763103374061,1.0,4/11,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,transaminase activity (GO:0008483),-0.5457981692034759,-1.3116821464482449,0.15384615384615385,0.6154101245823667,1.0,5/11,34.61%,ABAT;AGXT;BCAT1;GOT1;PSAT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.589527205859951,1.3105217895782089,0.1743119266055046,0.6698260945847346,1.0,4/12,10.32%,SLC25A17;SLC25A24;SLC35B3;SLC25A5
prerank,CoA-ligase activity (GO:0016405),-0.5131785228420658,-1.3088829529640633,0.16363636363636364,0.6134018658664998,1.0,7/14,33.80%,ACSS1;ACSS3;SLC27A2;ACSBG1;ACSF3;ACSS2;AACS
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.33388355298512856,1.3065311115628926,0.009146341463414634,0.6745295705366053,1.0,159/732,18.37%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;FOXN2;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;NR2C1;FOXA3;RAX;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;ZNF296;SP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;CHD2;SP3;NFIX;FOXO1;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;ZGPAT;ZNF569;PER1;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;NACC1;CARF;ZBTB7A;NR2F2;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ATF2;RFX3
prerank,microtubule minus-end binding (GO:0051011),-0.518995955743688,-1.3054743872745143,0.16981132075471697,0.6139705503754719,1.0,6/13,12.95%,CAMSAP1;MACF1;TUBGCP5;HAUS7;NUMA1;TUBGCP3
prerank,tRNA methyltransferase activity (GO:0008175),-0.49962175959426325,-1.3049440415775677,0.13752913752913754,0.6054111628674512,1.0,7/16,15.38%,TRDMT1;METTL2B;METTL2A;TRMT12;ALKBH8;BCDIN3D;TRMT9B
prerank,anion transmembrane transporter activity (GO:0008509),-0.5228729787481743,-1.3014108938437774,0.14317673378076062,0.6067879380797917,1.0,3/12,12.00%,SLCO2B1;SLC4A2;ABCG2
prerank,phosphatase binding (GO:0019902),0.3843567165582229,1.3010054483200562,0.107095046854083,0.6840290378274099,1.0,22/105,12.59%,EGFR;MAP3K5;SPRED1;IQGAP1;CTSC;RCAN3;MTMR3;AP3B1;RACK1;SNX3;WNK1;CDC27;CD33;MAPK14;NFATC2;PPP1R3C;STAT6;CHCHD3;PXN;JUP;JAK1;TERF2IP
prerank,Tat protein binding (GO:0030957),0.6025771583757564,1.3009856677615506,0.1848906560636183,0.6766089535090822,1.0,3/10,5.88%,MDFIC;ACTB;TRIM32
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.4263081080901406,-1.2995330769589877,0.11956521739130435,0.6025773641142007,1.0,16/28,31.87%,SGK1;MAPK10;RPS6KA1;MAP2K7;RPS6KA2;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5;RPS6KB1;AURKB;AKT1;TTK;MAP2K3;AURKA
prerank,P-type ion transporter activity (GO:0015662),0.5697579598819188,1.2976090718671462,0.1867145421903052,0.6793739520172191,1.0,4/12,14.25%,ATP2B1;ATP7A;ATP2B4;ATP2A2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3314061754999958,1.2974269108027827,0.013211382113821139,0.6726156550095046,1.0,160/731,18.37%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;NR2C1;FOXA3;RAX;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;TRIM24;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;ZNF296;SP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;CHD2;SP3;NFIX;FOXO1;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;CREB3L1;ZGPAT;ZNF569;PER1;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;NACC1;CARF;ZBTB7A;NR2F2;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ATF2;RFX3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.547411534403663,-1.2971981275394409,0.14989733059548255,0.6006200045219826,1.0,9/12,37.18%,CYFIP2;DCPS;NCBP1;EIF4E;LARP1;NCBP3;EIF4E2;GEMIN5;NCBP2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.33016927367921534,1.295532249868877,0.006072874493927126,0.6710260442586644,1.0,180/831,18.37%,RBPJ;ZEB2;MAF;TRPS1;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;HIVEP2;NFXL1;ESR1;ZBTB20;RARG;RPS3;TCF12;MEF2C;NR1H4;CEBPB;MITF;OSR1;KLF6;TBX15;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;RB1;KLF9;NFIC;BATF2;SMAD4;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;FOXM1;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;REL;THAP11;SATB2;STAT4;CEBPG;E2F5;NR4A2;LHX5;NRIP1;IRF2;KLF10;IRX5;ZBTB5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;OLIG2;HIVEP1;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;PURA;H3-3A;ZNF205;RFX2;ZNF296;CREBRF;SP1;TFDP1;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;FOXK1;ZBTB8B;ZFP3;CHD2;SP3;NFIX;FOXO1;GTF2A1;CREB1;PEG3;KLF13;ZBTB7C;NR1H2;ZBTB10;RARA;HIF3A;STAT3;KLF5;PROX2;JUND;USF1;MYC;MTF1;MYT1;HDAC4;NR2C2;RUNX3;ELK1;E2F8;ZFP62;HOXB3;POU5F2;ZGPAT;ZNF569;PER1;GTF2B;ZNF177;TBX2;NFATC3;ARNT;GLIS2;FOXP2;NR5A2;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;XBP1;MEF2B;MECOM;ZFP28;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;ZBTB1;MAFB;ZBTB8A;ATF2;RFX3
prerank,frizzled binding (GO:0005109),0.46553550424681334,1.2942339165518766,0.15,0.6677508020013508,1.0,6/34,10.04%,LRP6;WNT2;ZNRF3;SDCBP;WNT6;SFRP1
prerank,chemorepellent activity (GO:0045499),-0.4407390275480805,-1.293648206996572,0.13106796116504854,0.6016027588379577,1.0,5/25,5.59%,NRG3;SEMA4D;EPHA7;SEMA4C;SEMA4G
prerank,histone acetyltransferase activity (GO:0004402),0.4712306080179063,1.2934706250294086,0.16451612903225807,0.6631991409930735,1.0,13/30,18.44%,NCOA3;CLOCK;EPC1;EPC2;ARRB1;CREBBP;HAT1;KAT7;EP300;KAT6A;USP22;ATF2;SRCAP
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47605992628620075,1.2927406591569324,0.16176470588235295,0.6586707564385557,1.0,7/30,12.48%,TNFAIP8;GAS6;RPS6KA3;BIRC3;BIRC6;CARD16;CAST
prerank,5'-3' exonuclease activity (GO:0008409),0.5514235348319687,1.2896428654969705,0.1847246891651865,0.6610503572820805,1.0,6/14,21.07%,DCLRE1C;CPSF3;DCP2;DXO;MRE11;TRIR
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.40558891645368056,1.2875954237869158,0.12834978843441466,0.6601616329186397,1.0,17/75,14.64%,KCNAB2;SORD;DHRS3;HMGCR;EHHADH;HIBADH;HSD3B7;ABCC4;IMPDH2;HSD17B7;DHDH;CRYL1;HADH;HADHA;HADHB;KCNAB3;CBR3
prerank,transcription cis-regulatory region binding (GO:0000976),0.3364718735050375,1.285487478654752,0.034334763948497854,0.6598285442283313,1.0,87/406,17.48%,TRPS1;TCF7L2;FOXP1;FLI1;MEF2A;AHR;RREB1;FOXN2;NFXL1;ZBTB20;RPS3;TCF12;MEF2C;NR1H4;CEBPB;OSR1;ARID4B;HOXD8;PHOX2A;FOXA3;ALX1;NR1D1;NR3C1;GRHL2;SPI1;RB1;ARID5A;SMAD4;FOSL2;TCF7;FOXM1;ZNF568;TNF;KLF4;YY1;SATB2;TBL1XR1;LHX5;IRF2;KLF10;NCOR1;ZBTB5;ATF6;FOXC2;ESRRB;ASH2L;TBL1X;MLXIP;STAT6;PURA;CREBRF;SP1;TFDP1;FOXK2;HINFP;FOXO3;FOXK1;ZBTB8B;ZFP3;SP3;PEG3;PSPC1;ZBTB10;RARA;HIF3A;STAT3;BCOR;JUND;MYC;MTF1;HDAC4;NR2C2;SFPQ;RUNX3;ELK1;E2F8;CREB3L1;PER1;ZNF177;ARNT;GLIS2;NR5A2;RELA;LHX1;ZNF22;XBP1;ARID4A
prerank,I-SMAD binding (GO:0070411),-0.5095526632893524,-1.2828410731241666,0.18843683083511778,0.6249458635605939,1.0,3/13,2.02%,TGFBR1;CTNNB1;SMAD7
prerank,ephrin receptor binding (GO:0046875),0.5003511805302046,1.2807635968554945,0.1708542713567839,0.6669769178790791,1.0,6/21,11.24%,LYN;ANKS1A;CBL;CRK;FYN;SHC1
prerank,protein tyrosine kinase binding (GO:1990782),0.40414901130735414,1.2806229556475337,0.14008941877794337,0.6607255547907083,1.0,10/71,7.84%,BANK1;NEDD9;GAS6;ITGB1;CASS4;CBL;CRK;RACK1;DUSP22;FIZ1
prerank,MAP-kinase scaffold activity (GO:0005078),0.5798365753290615,1.2790884359849468,0.19705340699815838,0.6589630292115036,1.0,3/11,8.50%,IQGAP1;SH3RF1;MAPK8IP2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3953204309907277,-1.2782651696326406,0.12266666666666666,0.6292473100682106,1.0,16/31,28.69%,SLC12A2;TMEM38B;SLC12A9;KCNA1;KCNA2;SLC12A6;KCNK9;ABCC9;SLC12A4;TMEM175;SLC12A5;ABCC8;KCNC4;SLC12A1;KCNK10;KCNK3
prerank,death domain binding (GO:0070513),0.5838570207744325,1.2755127648962006,0.19540229885057472,0.6625942038784373,1.0,4/11,6.34%,RIPK1;MCL1;RACK1;BCL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.4410697208552763,-1.2736862987758233,0.14769975786924938,0.6332040600346677,1.0,5/20,5.09%,SENP2;OTULINL;OTUD5;SENP5;USP50
prerank,O-methyltransferase activity (GO:0008171),-0.5443144505587192,-1.273680565394842,0.20118343195266272,0.6239226805283647,1.0,5/10,21.94%,COMT;FTSJ3;MEPCE;BCDIN3D;ASMT
prerank,titin binding (GO:0031432),-0.5028180396983133,-1.269645032019541,0.17647058823529413,0.6270018077214459,1.0,5/13,21.06%,CAPN3;CALM2;ACTN2;CAMK2D;CALM3
prerank,guanyl ribonucleotide binding (GO:0032561),0.3524731812682042,1.2682528933721284,0.0893719806763285,0.6773418632568518,1.0,31/196,10.59%,RAP1B;RAB31;RAP2B;ATL1;GBP3;MFHAS1;NRAS;KRAS;GNAI3;EEF1A1;CNGA3;CDC42;RAB8B;RAB10;ARL8A;RHOA;RAPGEF2;PDE2A;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;TUBB6;ARL4A;PDE5A
prerank,nuclease activity (GO:0004518),0.42592041548716125,1.2666838621267655,0.15419161676646706,0.6751587873728436,1.0,17/52,20.20%,ENDOG;ANG;RNASE4;SND1;DNASE1L1;RNASEL;RNASE6;ZC3H12A;DIS3L2;SAMHD1;RNASE3;RNASE12;ENPP1;APEX1;MRE11;ERN2;REXO5
prerank,tau-protein kinase activity (GO:0050321),0.4993983409225389,1.2642578791926655,0.1738382099827883,0.6751277474685601,1.0,6/20,11.99%,GSK3B;ROCK1;FYN;DYRK1A;MARK2;ROCK2
prerank,nuclear receptor binding (GO:0016922),0.3728732176425134,1.2629469881273743,0.11378848728246319,0.6727158431200462,1.0,41/111,19.93%,TCF7L2;FOXP1;ESR1;NCOA3;NR1H4;NCOA2;NCOA7;ARID5A;NR4A1;WIPI1;MED16;PRKCB;NR4A2;NRIP1;NCOR1;TRIM68;NCOA6;ASXL1;LCOR;RNF14;JMJD1C;JUP;GAS2L1;BUD31;STRN;BCAS3;EP300;MMS19;SNW1;ARID1A;KDM1A;PPARGC1B;GTF2B;MED17;ZBTB7A;GTF2H1;KDM4C;THRAP3;RNF6;CNOT1;MED14
prerank,calcium-activated potassium channel activity (GO:0015269),-0.520122565337132,-1.262029761542055,0.1822125813449024,0.6410983916958398,1.0,1/11,0.07%,KCNMA1
prerank,transcription coactivator binding (GO:0001223),0.5053710252426221,1.2598628056443046,0.20347826086956522,0.6749507424934863,1.0,5/20,5.57%,AHR;ESR1;RPL23;SMAD4;THRB
prerank,GTPase regulator activity (GO:0030695),0.3465912440717622,1.258481922646002,0.099882491186839,0.6723798239341425,1.0,32/212,7.72%,ARHGAP15;STARD8;VAV3;IQGAP2;NRP1;GNAQ;IQGAP1;ARHGAP9;TBC1D5;TBC1D4;OPHN1;ARAP1;EVI5;RIN2;RASA1;USP6NL;DOCK1;ARHGAP10;ARHGAP18;ARHGEF10L;ARHGAP31;RAPGEF2;ITGB1BP1;NPRL3;OCRL;TBC1D14;RGS8;ARHGAP29;STXBP5;TBC1D2B;RABGAP1L;SGSM1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5528216699228876,1.257834942393996,0.20701754385964913,0.6682693967254937,1.0,4/13,9.45%,PTPRJ;ERN1;PDGFRA;PDGFC
prerank,protein homodimerization activity (GO:0042803),0.3264788013352457,1.2568721971581536,0.03336809176225235,0.6650182061508899,1.0,132/589,17.95%,SNX2;HIP1;NLRC4;LRP6;EXT1;APOE;FGFR1;MAP3K5;SNX9;AHR;ZBTB16;CPQ;KIF20B;KMT2A;GBP3;DPYD;ANG;ST6GAL1;IRAK3;CEBPB;ADRB2;GYG1;S100A1;XDH;RIPK1;LILRB1;PRKRA;ERN1;SNX6;AXIN1;STARD3NL;UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1;CLN6;S100A11;HMOX1;S100A10;B2M;PDE2A;AOC1;MGAT2;XPNPEP3;NPR3;GCH1;MCL1;NQO2;GNPTG;RACK1;SMAD4;BCL2L2;ANO1;PDGFRA;GUCY2D;DROSHA;BCL2;PEX7;CR2;HSPB1;CACYBP;BST2;VPS4B;AOX1;IL6R;TRIM68;GTF2A2;RABEP1;ZDHHC3;TKT;TRIM27;PLN;MAPK4;LRRFIP1;PDGFC;LHPP;RIPK2;KYAT1;ATG7;CRYL1;SP1;ACHE;JUP;STK10;CRYAB;XPA;SLC8B1;PANK1;RBM11;MAP3K11;BANF1;RBPMS2;SHMT1;MID2;STAT3;ADD1;TERF1;USF1;CNOT9;PKD2;ACP3;ABCB7;BMPR1A;SPPL2B;CLCN1;SFPQ;ZDHHC2;IDH1;HSP90AB1;MKLN1;PAFAH1B2;MTMR1;SPPL2A;ARNT;FOXP2;BNIP3;CCL5;RELA;MFSD1;ABCB10;DGCR8;NR2F2;RDH5;FAP;NR6A1;MID1;S100A6;PRPS1L1;PRPS1;PIP4K2A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5539060447733771,1.2567204778379057,0.22201834862385322,0.659505221719822,1.0,5/12,6.13%,PDE7B;PDE2A;PDE8A;PDE4D;PDE7A
prerank,GTPase binding (GO:0051020),0.3467493217579277,1.256553855681447,0.10144927536231885,0.654157582940446,1.0,27/195,8.80%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;STK19;EVI5;RASA1;USP6NL;SPTBN1;RILP;EXPH5;LCP1;EHD1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;GNB1;RANBP9;RCC2
prerank,protein heterodimerization activity (GO:0046982),0.3556765274839871,1.2564459469001494,0.10462287104622871,0.6487413756255112,1.0,39/178,17.28%,SNX2;HIP1;EXT1;CYBB;TCF4;MEF2A;AHR;ITGB1;IRAK3;MEF2C;TLR4;KRT10;MCL1;BCL2L2;NR4A1;BCL2;SDCBP;NR4A2;ATF6;GTF2A2;ADRA1A;PPP2CA;YWHAE;KCNB1;RALGAPA2;VAPA;GTF2A1;PAFAH1B1;ATP1A1;ADD1;USF1;CYBA;HEXA;ZHX1;PAFAH1B2;TOP2B;ARNT;RALGAPB;XBP1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5386959559969549,-1.2558552429104886,0.18859649122807018,0.6508469118452926,1.0,3/10,14.58%,SIRPA;CD200;CXADR
prerank,WW domain binding (GO:0050699),0.4717838150742164,1.2553590759633673,0.1716171617161716,0.6461500092551857,1.0,8/26,14.65%,KIF20B;RAPGEF2;NDFIP1;TCEAL6;PMEPA1;TCEAL8;NDFIP2;DAZAP2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3882961603930781,1.2517459453674957,0.15172413793103448,0.6509833815037342,1.0,12/82,12.48%,SERPINB8;APP;SERPINB2;RARRES1;ROCK1;ANXA2;BST2;BIRC6;CARD16;PROS1;USP14;CAST
prerank,small GTPase binding (GO:0031267),0.3494771955387392,1.2509520306068633,0.11910669975186104,0.6477290709322948,1.0,27/170,11.18%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;STK19;EVI5;USP6NL;RILP;EXPH5;EHD1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;RANBP9;RCC2;DOCK7;MYO1C;PDE6D;CHM
prerank,sodium channel regulator activity (GO:0017080),-0.378700912064103,-1.250871991310448,0.13513513513513514,0.6573342734484975,1.0,7/37,4.15%,FGF14;FGF12;YWHAH;SCN1B;SNTA1;SGK1;FGF13
prerank,aspartic-type peptidase activity (GO:0070001),-0.5367598097442303,-1.2498232689018882,0.1915367483296214,0.6516477720575564,1.0,2/10,5.48%,CTSD;CTSE
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.4653161076594183,-1.2489579709423373,0.17632850241545894,0.6454155498913482,1.0,8/17,25.43%,ACOT9;PLA2G6;PPT1;ACOT7;THEM4;ACOT11;ACOT8;ACOT1
prerank,MHC protein binding (GO:0042287),0.4871942616840075,1.2478667529089966,0.2053872053872054,0.6505367354333466,1.0,3/20,4.52%,LILRB1;CD74;KIR3DL2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.533100621507552,-1.2451844520434692,0.2170212765957447,0.6479755770081835,1.0,3/10,15.27%,SLCO2B1;SLCO4C1;SLCO4A1
prerank,E-box binding (GO:0070888),0.45219446660824036,1.243421627396949,0.1977124183006536,0.6574375067748124,1.0,4/34,4.61%,TCF4;AHR;MITF;CLOCK
prerank,vinculin binding (GO:0017166),0.563282538070426,1.2420013551878433,0.2247191011235955,0.6557542154376876,1.0,3/11,10.66%,CTNNA1;UTRN;PXN
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5065255258242598,-1.2411066381427456,0.2113289760348584,0.6518711042102657,1.0,4/12,11.34%,SLC36A1;SLC38A7;SLC36A4;SLC7A8
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5232391126370584,-1.2385591072007152,0.21518987341772153,0.6505704741038569,1.0,5/11,23.50%,NAA40;NAA60;NAA25;NAA80;NAA30
prerank,pyridoxal phosphate binding (GO:0030170),-0.43994211658104976,-1.2377308756366012,0.1935483870967742,0.6447911022946465,1.0,13/20,37.03%,ABAT;ACCS;PYGL;PLPBP;PYGB;AGXT;CBS;SHMT2;PYGM;THNSL2;PSAT1;CTH;GLDC
prerank,calcium channel activity (GO:0005262),-0.3215078801866211,-1.2359947465942673,0.11029411764705882,0.6417262063969925,1.0,25/84,19.51%,CACNB2;CACNB4;SLC24A3;SLC24A2;TRPC4;CACNA2D3;CACNA2D1;ORAI2;CACNA1D;TRPC1;SLC24A4;CACNA1E;TRPC3;CACNG7;CACNA1C;TRPC5;CACNG8;ANXA9;SEC61A1;CACNG4;SLC24A5;NCS1;ITGAV;ORAI3;CACNG2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.48008792475115414,1.2316831078098813,0.20408163265306123,0.6794365102255144,1.0,6/21,6.13%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3834264849933101,1.2303387430301806,0.1991701244813278,0.6777686993536681,1.0,10/72,6.90%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;STXBP6;ANXA2;PLCD1;SDCBP
prerank,antiporter activity (GO:0015297),0.48249136684107724,1.2267989764545253,0.21291448516579406,0.6818455212048394,1.0,5/20,16.00%,SLC25A16;SLC35E3;TMEM241;ATP1A3;SLC25A30
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5282819603927845,-1.224246689629058,0.23903508771929824,0.6672686154053871,1.0,5/10,29.27%,ASH1L;SETD3;SETD2;PRDM9;SMYD2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.47324955702737437,-1.222376130494077,0.22018348623853212,0.6563587576063434,1.0,7/16,15.95%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.47324955702737437,-1.222376130494077,0.22018348623853212,0.6563587576063434,1.0,7/16,15.95%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,phosphate ion binding (GO:0042301),0.5622014235468593,1.2220760588039805,0.22986247544204322,0.6894950113816847,1.0,4/10,16.92%,PDE2A;ADSS2;ADSS1;RELA
prerank,manganese ion binding (GO:0030145),-0.35779353248241574,-1.2191928385444828,0.1566265060240964,0.6580662757693841,1.0,16/48,17.33%,LARGE1;MPPED2;MGAT5;GALNT3;PPM1M;FAM20C;PRIMPOL;DYRK2;POMGNT1;PCK2;XPNPEP1;ADPRM;ATP13A2;XXYLT1;B4GALT7;MGAT1
prerank,neuropeptide receptor activity (GO:0008188),-0.38462656181349586,-1.2180358153213597,0.17708333333333334,0.6534977320436038,1.0,4/29,10.67%,SORCS1;HCRTR2;SORCS3;TACR3
prerank,heme binding (GO:0020037),0.39264345509060355,1.2164703881997663,0.18930041152263374,0.6994911886856576,1.0,11/65,10.66%,CYBB;NR1D1;HMOX1;THAP4;CYP27A1;RSAD1;HMOX2;BACH1;CYCS;CYP26B1;PXDN
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4517266621375563,1.2161546344019287,0.23129251700680273,0.6949228123205637,1.0,8/27,14.66%,SLC9A9;SLC9A4;SLC8B1;SLC9A7;SLC9A6;SLC23A1;PKD2L1;CNNM4
prerank,G protein-coupled receptor binding (GO:0001664),0.35481955825706546,1.2141606728258136,0.15523932729624837,0.694948740444569,1.0,19/132,11.26%,LRP6;GNAQ;GNAI3;WNT2;CCL19;ADM;PRKN;ZNRF3;GHRL;GPRC5B;S1PR2;CCRL2;SDCBP;WNT6;ARHGEF12;HOMER1;SFRP1;ARRB1;S1PR1
prerank,pre-mRNA binding (GO:0036002),-0.4039362656373486,-1.2119492144588357,0.20596205962059622,0.6636137044435002,1.0,14/28,32.02%,DDX5;HNRNPU;CELF4;U2AF1;HNRNPA1;TARBP2;U2AF2;CELF5;SLBP;SRSF6;TRA2B;SNRPC;U2AF1L4;PTBP1
prerank,cyclic nucleotide binding (GO:0030551),0.46813882547423896,1.2109225646581994,0.22491349480968859,0.6988253375112393,1.0,6/21,14.08%,CNGA3;RAPGEF2;PDE2A;PDE4D;PDE5A;POPDC3
prerank,telomeric DNA binding (GO:0042162),-0.3739399864502087,-1.2103501357561992,0.17994858611825193,0.6603747912607667,1.0,9/32,13.42%,XRCC5;CTC1;NCL;HNRNPA2B1;STN1;BLM;UPF1;TERF2;XRCC6
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.504000278678355,-1.2100388733508005,0.23529411764705882,0.6537361171571103,1.0,4/11,21.34%,AKR1B1;RDH14;DHRS13;AKR1B10
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3301179758007031,1.2097027698879794,0.13220338983050847,0.6972335926281341,1.0,53/232,15.31%,WWP1;RNF150;SMURF2;ARIH1;PIAS1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;PIAS2;TRIM24;NSMCE2;DTX2;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;ASB12;BFAR;NEDD4L;MKRN2;RNF122;RNF41
prerank,G protein-coupled receptor activity (GO:0004930),0.33299497140369155,1.20955653156065,0.13876146788990826,0.6923516402897644,1.0,23/239,8.64%,ADGRE5;HRH1;ADGRG6;ADGRE1;CMKLR1;C5AR1;C3AR1;CYSLTR1;CALCRL;ADRB2;GPR65;DRD1;P2RY6;NPR3;TM2D1;S1PR2;P2RY10;ADCYAP1R1;RRH;GPR52;CXCR4;ADRA1D;ADRA1A
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5473841858940681,1.207921349206682,0.2413127413127413,0.6915813200983314,1.0,3/11,12.36%,SASH1;STK38;MAP3K11
prerank,TBP-class protein binding (GO:0017025),0.47430344516190504,1.207901607645037,0.22021660649819494,0.6864844004885979,1.0,7/21,18.86%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;TAF12;THRA
prerank,solute:sodium symporter activity (GO:0015370),0.4532972219328408,1.2068646854116938,0.21465076660988075,0.6842513829761567,1.0,6/27,17.95%,SLC28A2;SLC4A4;SLC4A5;SLC5A6;SLC5A11;SLC5A3
prerank,histone demethylase activity (GO:0032452),0.45382430742453284,1.2067257194652046,0.23283082077051925,0.6796102455933828,1.0,11/27,20.67%,PHF8;JARID2;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A;KDM4C;JMJD6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5092793711456903,-1.2049919693159625,0.23486682808716708,0.6611637198284063,1.0,4/10,19.41%,CASP7;CFLAR;CASP6;CASP12
prerank,lipoprotein particle receptor binding (GO:0070325),0.44940018091704836,1.1955624693995557,0.23624595469255663,0.7054178884431336,1.0,2/27,1.61%,APOE;CLTC
prerank,deoxyribonuclease activity (GO:0004536),0.5133977333902398,1.1952525200165611,0.27413127413127414,0.7011611241377477,1.0,5/14,19.71%,RPS3;DNASE1L1;ZRANB3;APEX1;MRE11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.47041541736397796,1.195089254034131,0.27164685908319186,0.6965054331347967,1.0,2/22,1.61%,APOE;CLTC
prerank,"DNA binding, bending (GO:0008301)",-0.46794032275718517,-1.1949173892003844,0.22747747747747749,0.6821834551137008,1.0,9/14,34.71%,TOP2A;SAP30L;TFAM;FOXC1;HMGB1;LEF1;HMGB3;FOXD1;HMGA2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5463065624348302,1.1949149829995607,0.27697841726618705,0.6920855816160049,1.0,3/11,10.21%,SLC25A17;SLC25A24;SLC35B3
prerank,metal ion binding (GO:0046872),0.3137116920421461,1.1944333634733655,0.08851422550052687,0.6883854805925613,1.0,65/477,12.39%,ITSN1;AOAH;MCTP1;NLRC4;APOE;PADI4;MAP3K5;CHP2;IQGAP1;PPP3CA;CLEC6A;CDC42BPG;TPT1;S100A4;IRAK3;CALML4;OXSR1;RCN3;S100A1;STIM2;THBS4;ERN1;MOV10L1;S100A11;RAPGEF2;S100A10;LCP1;PDE2A;AOC1;CAMKK2;ACER3;SLC25A24;STK3;ANXA2;PAM;NUCB2;NUDT22;PLA2G2D;STIM1;CANX;MCTP2;GEM;CLYBL;TKT;TRIM27;DCHS1;CDH12;MAP3K20;MAST1;TESMIN;MARK2;CALM1;TRPM2;CETN2;SLIT3;SLIT1;CEMIP2;FOXK2;PLSCR4;GJB2;STK38;MICU3;PRKACB;NUCB1;LOXL2
prerank,calcium ion binding (GO:0005509),0.31887086853315605,1.1909829911363397,0.1251360174102285,0.692804047142098,1.0,44/323,12.39%,ITSN1;AOAH;MCTP1;PADI4;CHP2;IQGAP1;PPP3CA;CLEC6A;TPT1;S100A4;CALML4;RCN3;S100A1;STIM2;THBS4;S100A11;RAPGEF2;S100A10;LCP1;AOC1;CAMKK2;ACER3;SLC25A24;ANXA2;PAM;NUCB2;PLA2G2D;STIM1;CANX;MCTP2;TKT;DCHS1;CDH12;CALM1;TRPM2;CETN2;SLIT3;SLIT1;CEMIP2;PLSCR4;GJB2;MICU3;NUCB1;LOXL2
prerank,endopeptidase activator activity (GO:0061133),0.5467599579274123,1.1903931699575743,0.25375939849624063,0.6895297760841973,1.0,1/10,0.36%,NLRC4
prerank,alpha-actinin binding (GO:0051393),0.45979841194453125,1.1902963648236673,0.25546218487394956,0.6849745975642019,1.0,6/24,14.70%,PDLIM5;NRAP;PDLIM1;RARA;PKD2L1;PKD2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.45631745945130453,1.190191911301592,0.2521440823327616,0.6804351471764154,1.0,6/23,6.13%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,phospholipid transfer activity (GO:0120014),0.46291518401862286,1.188550117322682,0.25412541254125415,0.6804230635656566,1.0,3/21,9.15%,PLTP;PITPNA;GLTP
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.48728038185944555,-1.1879458503362292,0.2663755458515284,0.6948231158316894,1.0,2/13,1.14%,LPCAT2;LPCAT1
prerank,FMN binding (GO:0010181),-0.4948602870274818,-1.18784725352621,0.28929384965831434,0.6875061975311756,1.0,1/11,0.55%,PPCDC
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4022554131708489,1.1852872029373602,0.2168141592920354,0.6845506001894591,1.0,10/53,10.17%,CYBB;DPYD;XDH;DAO;NQO2;AGPS;AOX1;ETFDH;ETFA;SDHA
prerank,phospholipase A2 activity (GO:0004623),0.44432292908653553,1.1838489365561884,0.25418060200668896,0.6836724594778458,1.0,5/26,14.62%,PLA2G7;PNPLA8;PLA2G2D;PLAAT1;PLAAT3
prerank,mRNA 5'-UTR binding (GO:0048027),0.4595142204746122,1.1818827720884317,0.25261324041811845,0.6841607499441774,1.0,7/24,9.26%,RPL26;RPS13;RPL41;RPL5;RPS14;RPS7;MRPS11
prerank,GTP binding (GO:0005525),0.3349407071463431,1.1818512832218262,0.18,0.679628136621462,1.0,25/172,10.26%,RAP1B;RAB31;RAP2B;ATL1;GBP3;MFHAS1;NRAS;KRAS;EEF1A1;CDC42;RAB10;ARL8A;RHOA;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;TUBB6;ARL4A
prerank,kinase binding (GO:0019900),0.31074270808303633,1.179843920555952,0.10583153347732181,0.6805932457674115,1.0,86/434,14.50%,AP2A2;EGFR;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;DNAJC3;RPS3;IRAK3;PTPN22;OXSR1;EEF1A1;MYH6;MYOM2;PRKAG3;CDC42;GDF3;MAP3K1;AXIN1;CRK;RHOA;UTRN;RGCC;PRKN;BCL10;PDE8A;NR3C1;DOK7;GSK3B;PGAM1;RB1;GPRC5B;PAK2;PTPRK;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;MOB1B;IFNAR2;RHOBTB1;TRIM68;MAPK8IP2;VRK1;MSN;TRIM27;RCC2;MAPK4;SMCR8;RPS7;CARD16;CCND2;CACUL1;ACSL3;PIP5K1A;PARP16;RPS6;SP100;MAML1;CALM1;SPRED2;SHC1;IL15RA;FOXO3;CDKN2C;NOD2;EXOC2;RBBP6;RND3;CTBP2;CNTLN;FAM83B;IBTK;STAT3;ATP1A4;ITGB2;RHOC;USF1;CNOT9
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.45705704073829156,-1.179274400119346,0.2595078299776286,0.7049101014874323,1.0,2/15,1.14%,LPCAT2;LPCAT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.46332965744585874,-1.1789043026184403,0.27593818984547464,0.6983878105713112,1.0,2/14,1.05%,CAPN15;CAPN3
prerank,tropomyosin binding (GO:0005523),0.485464462466887,1.178031584953681,0.26582278481012656,0.6810339400579276,1.0,3/16,4.86%,TMOD1;TNNT1;TMOD3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.35569062282327585,1.177071743072439,0.2300531914893617,0.6790497471522223,1.0,13/91,7.13%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;SNX3;STXBP6;KIF16B;ANXA2;PLCD1;SDCBP;WIPI1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5433275806384908,1.1741894478385186,0.2982791586998088,0.6818916548143068,1.0,7/10,28.33%,CDKN2C;HEXIM2;INCA1;CDKN1B;HEXIM1;KAT2B;CDKN1A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.38125223112641804,-1.174155871925716,0.236318407960199,0.7053177844073132,1.0,12/29,20.20%,HEXD;NEU1;GAA;HPSE2;GBA2;ABHD10;HPSE;ACER2;IDUA;OVGP1;ADPRS;PARG
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3909243773528725,-1.1738997907316675,0.2193211488250653,0.6984708784720866,1.0,14/24,32.61%,KCNJ2;KCNN2;ABCC9;KCNK6;KCNJ3;KCNJ10;KCNJ13;KCNJ9;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1;KCNJ6
prerank,receptor ligand activity (GO:0048018),0.3165239188025205,1.1738045720728354,0.16550925925925927,0.6784163155903586,1.0,27/245,10.69%,IL16;SEMA4A;IL15;GAS6;JAG1;TSLP;METRNL;KITLG;BMP2;FGF23;WNT2;C1QTNF12;ENDOU;GRN;GDF3;THPO;GDF10;FAM3C;TNF;EDA;WNT6;CCL24;TNFSF12;IGF1;CCK;METRN;DAND5
prerank,calcium channel regulator activity (GO:0005246),0.4198664898626545,1.1724603913831602,0.24769230769230768,0.6775978374114979,1.0,7/37,11.84%,MCUB;SGK3;STIM2;STIM1;GEM;CALM1;YWHAE
prerank,actin monomer binding (GO:0003785),0.4543072243283451,1.172104073044419,0.25862068965517243,0.674194578289157,1.0,1/22,0.25%,MTSS1
prerank,C-C chemokine receptor activity (GO:0016493),0.45888020361895004,1.1710357531149946,0.26773049645390073,0.6730023125393111,1.0,4/21,7.58%,CCR1;CCRL2;CXCR4;CCR2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4645337576686075,-1.1654595526158993,0.27654867256637167,0.7151324474748157,1.0,9/13,29.49%,GLRB;GABRA2;GLRA1;GABRG2;GLRA3;GLRA2;GABRA4;GABRG3;GABRE
prerank,C-C chemokine binding (GO:0019957),0.4506729843102366,1.1644430886670056,0.27845884413309985,0.6855594767521254,1.0,4/22,7.58%,CCR1;CCRL2;CXCR4;CCR2
prerank,ferrous iron binding (GO:0008198),-0.4032052552283026,-1.1624733726725087,0.2607655502392344,0.7163504333404552,1.0,7/21,11.25%,CDO1;PHYH;FECH;ALKBH2;ISCU;EGLN2;FXN
prerank,disordered domain specific binding (GO:0097718),0.44627727203266243,1.162304835206207,0.26981450252951095,0.686832435523424,1.0,9/23,16.01%,CLTC;NCOA3;RB1;BCL2L2;FYN;MDM2;CALM1;FN1;HSP90AB1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.427347115866423,1.1622406586256244,0.2634146341463415,0.6827353186871709,1.0,9/27,18.53%,TENT2;POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;CRCP;POLR2F
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5345918939755847,1.160359809636966,0.29714285714285715,0.6833540033106897,1.0,3/10,15.70%,DPYSL2;CRMP1;DPYSL5
prerank,ubiquitin protein ligase activity (GO:0061630),0.31692693399584426,1.1598413414528261,0.19204545454545455,0.6804094916204118,1.0,53/228,16.08%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;TRIM24;DTX2;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2K;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;ASB12;BFAR;NEDD4L;MKRN2;RNF122;RNF41;TRIM25;FANCL
prerank,phosphatidylcholine transporter activity (GO:0008525),0.47016545561150846,1.1568985297948213,0.304857621440536,0.6838006543084452,1.0,2/17,3.71%,PLTP;PITPNA
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.49285658921602016,-1.155731096682954,0.30353430353430355,0.7282328309707735,1.0,2/10,2.33%,EHMT2;ASH1L
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3259235390461238,1.155011177441436,0.21575757575757576,0.6844790443775927,1.0,40/173,18.57%,ZEB2;TRPS1;FOXP1;ZBTB16;TFEC;ZBTB20;CEBPB;MITF;NR1D1;NR3C1;HEY2;IRX2;ZBTB25;ZNF148;YY1;THAP11;ZBTB5;BACH1;LRRFIP1;NR2F1;ETS2;SREBF2;FOXK2;FOXO3;FOXK1;PEG3;MYC;E2F8;CREB3L1;ZGPAT;ZNF177;TBX2;NFATC3;FOXP2;RELA;NACC1;GZF1;ZBTB12;ZBTB1;ZBTB14
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.4745276729597879,-1.1523621097465564,0.2799097065462754,0.7307576996363874,1.0,4/12,14.99%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,DNA binding (GO:0003677),0.2947366635445927,1.1497980067648395,0.11440245148110317,0.6940631864518321,1.0,142/694,18.45%,RBPJ;ZEB2;EGFR;APP;KLF2;TCF7L2;TCF4;RBMS1;IRF4;FLI1;TLR8;MEF2A;AHR;ZBTB16;HIVEP2;NUPR1;RBBP8;ANG;RARG;RPS3;LIG4;NR1H4;CEBPB;DDX60;RYBP;TSHZ3;NR2C1;RPS15;MND1;HEY2;FAM111A;CLOCK;GRHL2;ARID5A;SMAD4;DCLRE1C;THRB;IRX2;CBFB;DNASE1L1;NR4A1;MCM9;ACR;BCL2;WDR76;CR2;ZNF148;TSHZ1;LYL1;YY1;THAP11;PDS5B;DDX11;CEBPG;TIPIN;RPA1;NR4A2;IRF2;ATF6;FOXC2;ARID3A;ESRRB;BRIP1;GTF3C3;GTF3C6;ESR2;LRRFIP1;FOXJ3;NFATC2;RAD52;NHEJ1;NR2F1;PURA;ILF3;RPL6;POLG2;RFX2;TRIM16;SP1;PCID2;ETS2;CENPB;CREBBP;FOXK2;XPA;HINFP;FOXO3;ZC3H12A;RPA3;CHD2;FOXO1;BANF1;GTF2A1;XRCC4;XPC;NR1H2;KIN;STAT3;MBD1;EP300;TERF1;CRLF3;KAT6A;POLR2D;SMARCAD1;USF1;RAD51B;MYC;SAMHD1;MTF1;HDAC4;NR2C2;SFPQ;ARID1A;FBH1;MCM8;ZGPAT;TBX2;ARNT;FOXP2;NR5A2;RELA;RBM6;CARF;ZBTB7A;TAF12;NR2F2;ZNF22;XBP1;RFC3;MECOM;ARID4A;DMC1;NR6A1;MPG;GZF1;BATF;APTX;MAFB;RFX3;RPL7;LONP1
prerank,ubiquitin protein ligase binding (GO:0031625),0.31032619081033436,1.1491201299186133,0.2,0.6917083366716466,1.0,71/254,20.10%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;CXCR4;RPL5;UBXN7;SPOPL;SHPRH;VCL;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;CASP8;WFS1;JAK1;YWHAE;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMA3;PSMD1;RPL11;ASB4;AMBRA1;GPI;NLK;USP25;GABARAP;HSP90AB1;UBE2W;FANCL;PER1;RELA;CUL5;PA2G4;GLMN;MID1;UBE2A;TNK2;TRAF6;ATXN3;SUMO1;TRIB1;SMC6;TMBIM6;DTX1;USP7;SMAD5
prerank,cholesterol transfer activity (GO:0120020),0.4867787938554701,1.1488839496470682,0.2962962962962963,0.6882046598517194,1.0,1/16,0.21%,PLTP
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4343047672154667,-1.1456270705199965,0.29082774049217003,0.7433349085262944,1.0,7/16,27.74%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4
prerank,thyroid hormone receptor binding (GO:0046966),0.4170749230044567,1.1445906364885463,0.2899022801302932,0.6952845398727019,1.0,12/28,20.83%,NCOA3;ARID5A;MED16;NCOR1;NCOA6;JMJD1C;GAS2L1;GTF2B;MED17;GTF2H1;THRAP3;TRIP12
prerank,sterol transfer activity (GO:0120015),0.4764339435347738,1.1397925555160793,0.3021978021978022,0.7036520501575521,1.0,1/17,0.21%,PLTP
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.47287218648117657,1.139638120255707,0.3132075471698113,0.6999731225349041,1.0,3/16,4.05%,MTM1;SYNJ1;MTMR3
prerank,histone deacetylase activity (GO:0004407),0.4465173748428534,1.137990077970816,0.30287648054145516,0.7000030289422738,1.0,1/19,0.10%,HDAC9
prerank,adenylate cyclase binding (GO:0008179),-0.4799230509790329,-1.1361280422106983,0.31965442764578833,0.7648767171998371,1.0,5/10,24.93%,CALM2;AKAP6;CALM3;ADCY5;AKAP5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5031716913364289,-1.1334084157579198,0.30952380952380953,0.765334194615311,1.0,4/10,4.67%,PRKAG1;PRKAR1A;PKIG;PRKAR1B
prerank,cysteine-type peptidase activity (GO:0008234),-0.2984507466568555,-1.132990126909543,0.22058823529411764,0.7592805846871582,1.0,20/73,16.38%,USP35;CAPN3;OTULINL;LGMN;USP12;USP50;OTULIN;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CASP6;USP49;USP34;USP29;USP5;CTSO;USP33
prerank,RNA binding (GO:0003723),0.2859465035472771,1.1299608453504788,0.07537688442211055,0.7167540437066775,1.0,274/1321,15.05%,AHNAK;DHX34;DHX8;MYO5A;RBMS1;CTNNA1;TLR8;OAS2;MBNL1;FNDC3A;DIAPH1;RPS23;TPT1;ZCCHC24;RPL17;MRPL23;RPL23;ZFP36L2;CLTC;MRPS12;RPS12;S100A4;ANG;RPS16;RPS3;RBM47;RPS27A;NOL6;EIF3E;DDX60;RCAN3;NCOA5;RPL39;RPS18;RPS21;SPTBN1;EEF1A1;RPL23A;PRKRA;ENDOU;ADK;RPS15;MOV10L1;HNRNPC;GRN;PPHLN1;RPL37;ANKRD17;KCTD12;SAMD4A;AGFG1;RPL26;TUT7;ZFP36L1;RPS10;FNDC3B;NYNRIN;RPS20;RPS13;ERAL1;RFTN1;SNU13;RPSA;VIM;LARP7;RPL41;RPS28;NKAP;TRIM56;MRPL13;RPL13;PTBP3;RPS24;RSL24D1;RPL24;RPL12;SND1;RPL36A;GTPBP10;RACK1;RPUSD3;RPS8;RPL18A;PKN2;TENT5A;SMG6;RC3H1;PUM2;NUFIP2;DROSHA;RPL37A;MANF;MBNL2;TBCA;RPS11;RPL28;RNASEL;TRIM32;WDR36;ANXA2;NMD3;DARS1;FARS2;NOP53;RPL30;HNRNPF;RPL8;RPL35A;RPS4X;RPS15A;RPL38;GLRX3;HSPB1;ZGRF1;RPS17;RPLP0;CPSF3;BST2;SF3B5;YY1;IBA57;SRSF4;RPL5;DDX11;RPL36;CANX;FLNB;CELF3;PTBP2;RPL14;LARP4B;STAU2;RBM4;PNO1;DCP1A;RPS14;RPL9;TUT4;RO60;EIF1;TDRD7;SNRPG;ACO1;RPS9;MSN;GRSF1;KMT2C;RCC2;SCAF8;RPS5;SELENOH;CCT6A;RPS7;ASCC3;LRRFIP1;RPL34;RPL27;ZCCHC7;MRPS11;COL14A1;MAP3K20;APOBEC1;MTREX;SERBP1;ZNF106;PURA;POLR2B;ILF3;RPL6;MKRN1;RTN4;HEATR1;RPL22L1;SRP68;HELZ;SLC25A5;RPS6;SEC63;NSRP1;SPEN;RBM15;RARS2;MARK2;MRPL1;FAU;NSUN2;PCID2;DDX6;RPP38;RPL4;EIF3I;EIF4B;SEPSECS;RBM27;DNAJC21;ASS1;GTF2E2;DCP2;RPL22;DUSP14;ZC3H18;SCAF4;PSMA6;LACTB2;CDK13;NANOS3;YWHAE;DHX40;RPL15;RPL10;MRPL16;LBR;ROCK2;ZC3H14;DHX33;RBM11;DDX10;RPL32;DEK;ZC3H12A;PDIA4;POLR1G;CAST;NUP98;MKRN3;ETF1;ELP5;CHD2;ESF1;GTPBP1;ZC3H12D;LSM4;GPATCH1;VIRMA;UBE2N;RBPMS2;RBBP6;PRPF38B;LARP4;AQR;R3HDM1;MRPL44;MAGOHB;LSM2;PSPC1;RPP30;DDX42;HADHB;ZNF326;RPL19;KIN;CTU1;STAT3;ANKHD1;RAMAC;MRPS14;ADD1;KPNA2;POLR2D;EXOSC1;RPL31;HMGN5;TPD52L2;EIF3H;RPL11;RTRAF;SNW1;PRMT1;PPIA;RPL7L1;RALY;NOVA1;MKRN2;SRBD1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3205904777667818,1.1280457850848395,0.24159402241594022,0.7176814925735253,1.0,47/188,18.86%,TCF7L2;FLI1;AHR;ZBTB20;TCF12;MEF2C;CEBPB;ARID4B;FOXA3;NR1D1;SPI1;ARID5A;SMAD4;TCF7;ZNF568;TNF;KLF4;YY1;TBL1XR1;NCOR1;ATF6;FOXC2;ASH2L;LIN54;TBL1X;SP1;FOXK2;HINFP;FOXO3;FOXK1;PSPC1;STAT3;BCOR;JUND;HDAC4;SFPQ;ELK1;CREB3L1;PER1;GLIS2;NR5A2;RELA;ARID4A;RFX3;ZBTB14;GABPB1;THRA
prerank,GTPase activity (GO:0003924),0.31175380503618894,1.1274616395419432,0.22798552472858866,0.7148551719154161,1.0,45/192,18.29%,GNAQ;RAP1B;RAB31;RAP2B;ATL1;GBP3;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;GEM;RHOBTB1;GNB1;RAB7A;RAB14;RAB1A;RAB23;GNG5;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;LSG1;GNA13;HBS1L;RAB32;RHOF;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,ubiquitin-specific protease binding (GO:1990381),0.4462592290183137,1.1268500533460444,0.3233333333333333,0.7123796776502224,1.0,8/19,18.84%,CLTC;PRKN;RHBDD2;LCOR;AMFR;DERL2;PTEN;SUMO1
prerank,miRNA binding (GO:0035198),0.4122240462263861,1.123432493571847,0.29853181076672103,0.7169111740165972,1.0,7/30,12.28%,TUT7;RC3H1;PUM2;RBM4;TUT4;TRIM71;ZC3H12A
prerank,MAP kinase kinase activity (GO:0004708),-0.42990104736424894,-1.121879031374893,0.3356009070294785,0.7847654606920116,1.0,7/15,24.78%,MAPK10;MAP2K7;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5
prerank,adenylyltransferase activity (GO:0070566),0.439899931302849,1.1188035957656768,0.33152173913043476,0.7244689059712899,1.0,6/21,16.36%,OAS2;TENT2;NMNAT3;NMNAT2;PAPOLA;TUT1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.46134455640032324,1.1185760076187294,0.3386243386243386,0.7209647364499385,1.0,1/15,0.51%,P2RX7
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.48204696250211726,1.1178876746775455,0.32771535580524347,0.7186634010480623,1.0,8/14,24.43%,USP9X;MINDY3;USP15;MINDY2;ATXN3;USP7;USP13;MINDY1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.3343858555345498,-1.1178695191572128,0.28254847645429365,0.789496141848805,1.0,18/40,34.65%,DNMT3A;METTL2B;METTL2A;COMT;AS3MT;SETD3;MEPCE;DNMT1;LCMT1;ASMT;PCMT1;PEMT;RRP8;METTL18;PRMT8;FBL;THUMPD3;LRTOMT
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4072867839865759,-1.1160079583719924,0.3391959798994975,0.7877314971083957,1.0,4/19,13.86%,GRID2;GRIK2;GABRA2;GABRG2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.36543983686375264,1.1157933907657624,0.30633284241531666,0.719973377278628,1.0,10/54,12.84%,HDAC9;HINT1;ACER3;HINT3;ACR;DARS1;MIER1;MIER3;NGLY1;GLS2
prerank,carbohydrate kinase activity (GO:0019200),0.5033368965952842,1.115033083591361,0.3513011152416357,0.7180811528711938,1.0,3/11,12.24%,POMK;FGGY;GALK2
prerank,poly(U) RNA binding (GO:0008266),0.44740267480253254,1.1139847087218768,0.3229166666666667,0.7168115248640078,1.0,5/20,12.66%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.49460725901084795,1.1138228030459985,0.3586337760910816,0.7133006566220843,1.0,1/11,3.05%,CNGA3
prerank,iron ion binding (GO:0005506),0.3781324335629165,1.1135870505025625,0.2998522895125554,0.7100033395086154,1.0,10/48,11.33%,ALOX5;ALOX15;AGMO;PHF8;FTL;KDM7A;FBXL5;AOX1;FTH1;ETHE1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.42126226806101785,-1.1134272305283253,0.32653061224489793,0.7883506383737615,1.0,4/15,18.66%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,ion channel inhibitor activity (GO:0008200),0.4030206901395386,1.1132426940070494,0.3241935483870968,0.7070641214729102,1.0,8/35,14.32%,MCUB;RASA1;RACK1;WNK1;STX7;CALM1;SCN3B;NEDD4L
prerank,protein phosphatase binding (GO:0019903),0.3262651204322426,1.1118417730569148,0.27116402116402116,0.7066223622447229,1.0,24/117,12.87%,EGFR;MAP3K5;IQGAP1;MFHAS1;LILRB1;MTMR3;AP3B1;RACK1;SNX3;CDC27;CD33;MAPK14;PPP1R3C;IGBP1;STAT6;PPP1R3D;PXN;JUP;ARPP19;JAK1;KCNQ1;STRN;ATP2B4;FOXO1
prerank,calcium channel inhibitor activity (GO:0019855),0.4959616077344996,1.1108116566360653,0.3500931098696462,0.7056309933855149,1.0,1/11,0.56%,MCUB
prerank,damaged DNA binding (GO:0003684),0.3744446418757549,1.1098315623575843,0.319634703196347,0.7043120571052627,1.0,14/44,20.20%,RBBP8;RPS3;DCLRE1C;RPA1;CREBBP;XPA;RPA3;XPC;EP300;MPG;APTX;APEX1;SMC6;PCNA
prerank,kinase activator activity (GO:0019209),0.4092150755848738,1.107973882850454,0.34065934065934067,0.7054648369692459,1.0,8/30,10.58%,PRKAG2;RPLP1;RGCC;BCL10;GPRC5B;WNK1;MOB1B;MARK2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3682109642147867,1.107745390692931,0.30927835051546393,0.7023077398184339,1.0,12/51,17.56%,SLC25A16;SLC28A2;SLC16A10;MCU;SLC4A4;SLC35E3;SLCO5A1;TMEM241;MFSD2A;SLC25A30;SLC5A6;SLCO2A1
prerank,peptidase activator activity (GO:0016504),0.4299272035759543,1.1006749080381049,0.3597972972972973,0.7155678592466599,1.0,4/22,11.58%,NLRC4;PCOLCE;CLPX;EBAG9
prerank,DNA secondary structure binding (GO:0000217),0.400248622005403,1.0991842545624733,0.33878887070376434,0.7154674316117062,1.0,7/31,14.89%,KMT2A;RBBP8;MEF2C;YY1;LIN54;XPC;RAD51B
prerank,water transmembrane transporter activity (GO:0005372),-0.4504939076138264,-1.0989143736364717,0.345679012345679,0.8242101324078867,1.0,5/11,49.89%,PDPN;AQP4;AQP1;SLC5A1;SLC4A11
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.39484763061356876,1.0968784278669315,0.33777038269550747,0.7174151093887843,1.0,9/33,13.63%,RPS3;ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF185;RNF19A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36141857857263543,1.0941225512422041,0.3227206946454414,0.7205273132494898,1.0,6/60,5.33%,NRP1;EGFR;FGFR1;CRIM1;INSR;PDGFRA
prerank,general transcription initiation factor binding (GO:0140296),0.41099630664149994,1.0939821290770877,0.35604770017035775,0.7171933830219367,1.0,8/25,18.86%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;RELA;TAF12;THRA
prerank,RNA polymerase II complex binding (GO:0000993),0.3922579791738281,1.0903165893551874,0.3610223642172524,0.7228644781694508,1.0,12/32,16.61%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B;BRD4
prerank,pentosyltransferase activity (GO:0016763),-0.33609313660316104,-1.08855294651052,0.32954545454545453,0.8489654202823333,1.0,13/36,18.39%,LARGE1;QTRT1;UPP2;UMPS;PARP1;SIRT2;PARP10;PARP3;PARP4;QTRT2;SIRT5;SIRT4;PARP9
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.35243074272320235,1.0879916710697903,0.31602373887240354,0.7249187327546562,1.0,16/60,16.43%,PPP3CA;MTMR3;DUSP1;CTDSP1;PPM1B;CTDSP2;PPP1R3C;PPP2CA;PPP2CB;PPP1R3D;PPEF1;PPP1CA;LRRK1;CTDSPL2;PTEN;PPM1A
prerank,transcription corepressor binding (GO:0001222),0.40180969749726253,1.0875031797509558,0.3606010016694491,0.722368810475539,1.0,8/27,17.18%,ZBTB16;ESR1;NR1D1;LCOR;CTBP2;EHMT1;PER1;ZBTB7A
prerank,androgen receptor binding (GO:0050681),0.41013952516125685,1.0872946588246502,0.3474576271186441,0.7192302382765877,1.0,12/25,19.28%,FOXP1;ARID5A;WIPI1;PRKCB;TRIM68;RNF14;EP300;SNW1;KDM1A;ZBTB7A;KDM4C;RNF6
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2802718102984739,-1.086634728358931,0.25517241379310346,0.8473171599884622,1.0,9/80,9.32%,KCNMA1;KCND2;KCNH7;KCNJ2;KCNQ3;KCNQ5;KCNK2;KCNA1;KCNA2
prerank,actinin binding (GO:0042805),0.43270638909382336,1.0840248431705577,0.346483704974271,0.723702004873152,1.0,5/21,16.92%,PDLIM5;RARA;PKD2L1;PKD2;RELA
prerank,diacylglycerol kinase activity (GO:0004143),-0.4529239068028937,-1.0810144185993846,0.37254901960784315,0.8571595966451836,1.0,7/11,30.67%,DGKI;DGKB;DGKZ;AGK;DGKG;DGKA;DGKQ
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.42132276582165895,1.0806418797128094,0.3546712802768166,0.7281925254467402,1.0,2/21,7.43%,P2RX7;CHRNA4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4492568459682171,1.0799782737483483,0.36727272727272725,0.7263352977158751,1.0,4/15,8.91%,KMT2A;ASH2L;KMT2C;WDR82
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3584303328727705,-1.0798370560331638,0.34438775510204084,0.8534528068974164,1.0,7/23,11.24%,PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,leucine zipper domain binding (GO:0043522),-0.4537540041139659,-1.079445138083526,0.38729508196721313,0.8470909810345573,1.0,4/10,29.04%,DDIT3;PAWR;ATF4;PMF1
prerank,protease binding (GO:0002020),0.32251771656981193,1.0781294868617797,0.3133159268929504,0.7275602255131148,1.0,17/99,11.25%,NLRC4;LDLR;CLTC;ITGB1;PRKN;BCL10;GSK3B;RIOK3;ANXA2;BCL2;TNF;STIM1;CARD16;RHBDD2;LCOR;RIPK2;AMFR
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5001315219969189,1.0780039170046345,0.3713235294117647,0.7243389053825439,1.0,4/10,18.87%,PHF8;KDM7A;KDM2A;KDM4C
prerank,transcription coregulator binding (GO:0001221),0.35625087599681593,1.077860522341908,0.3485540334855403,0.7211824054776463,1.0,7/50,5.57%,AHR;ZBTB16;ESR1;RPL23;NR1D1;SMAD4;THRB
prerank,protein serine/threonine kinase activity (GO:0004674),0.28426634079615176,1.0773552091196574,0.32079646017699115,0.718920547106045,1.0,60/335,12.36%,EGFR;MAP3K5;STK17B;SGK3;CDC42BPG;CASK;GRK5;STK19;DAPK1;IRAK3;ALPK1;OXSR1;RIPK1;ERN1;MAP3K1;CAMK1D;CDK12;RPS6KA3;CDK6;TRIO;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;STK24;STK3;RIOK3;WNK1;PIKFYVE;VRK2;ACVR2A;RPS6KC1;SYK;CHEK1;MAP3K8;FAM20A;NRK;HTATIP2;PRKCB;ULK2;CDK14;CDK20;VRK1;MAPK4;SBK3;MAPK14;DYRK1A;MAP3K20;MAST1;RPS6KA6;RIPK2;MARK2;STK10;CDK13;STK36;ROCK2;STK38;MKNK1;MAP3K11
prerank,GABA-A receptor activity (GO:0004890),-0.3914530073176238,-1.0773419518672425,0.36739659367396593,0.8460073201072394,1.0,8/18,29.49%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.44346793185269784,1.0757591272777203,0.3817204301075269,0.7190899337849397,1.0,2/17,1.73%,BLVRB;DPYD
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.27703436506795837,-1.0749540288617137,0.31690140845070425,0.8456895969756295,1.0,27/78,23.55%,USP35;CAPN15;CAPN3;LGMN;USP12;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CFLAR;CASP6;USP49;USP34;GPAA1;USP29;USP5;CTSO;USP33;PIGK;PYCARD;CASP12;CTSK;ESPL1;CAPN11;USP10
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.43026706409046,-1.074361046312805,0.37844036697247707,0.8402374118415713,1.0,4/13,18.66%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.27989648996194655,1.0742001284220706,0.31019978969505785,0.719478666184016,1.0,67/431,14.23%,NLRC4;P2RX7;MAP3K5;RAP1B;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;RAB31;RAP2B;ATL1;GBP3;MFHAS1;DAPK1;IRAK3;LIG4;NRAS;KRAS;OXSR1;EEF1A1;ERN1;MOV10L1;CDC42;RAB10;ARL8A;RHOA;GCH1;CDK6;RAP1A;PNPLA8;INSR;GBP7;GTPBP10;ATP7A;STK3;WNK1;NOL9;ZAP70;GEM;RHOBTB1;ADSS2;RAB7A;RAB14;MAP3K20;MAST1;PMVK;MTREX;TUBB6;ARL4A;CLPX;MARK2;PSMA6;HSPA13;STK36;STK38;PRKACB;MKNK1;GLUD1;RND3;LATS2;UHMK1;RALB;ATP1A3;ATP1A1;ADSS1;RHOC
prerank,microtubule plus-end binding (GO:0051010),-0.38420859525539064,-1.0740897697437681,0.35454545454545455,0.8339494665019542,1.0,7/20,16.02%,DST;CLASP2;CLIP2;MAPRE3;NUMA1;MAPRE1;CLIP3
prerank,potassium channel activity (GO:0005267),-0.278739479784038,-1.0739033804380913,0.30996309963099633,0.8274259783264127,1.0,17/89,18.03%,KCNMA1;KCND2;KCNH7;GRIK2;TMEM38B;KCNQ3;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12;KCNS3;KCNK9;KCNN2;ABCC9;KCNK6;KCNT1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.28759420295778104,1.0717426054551669,0.31477272727272726,0.7221657900385572,1.0,72/269,20.10%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;CXCR4;RPL5;UBXN7;SPOPL;SHPRH;VCL;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;CASP8;WFS1;JAK1;YWHAE;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMA3;PSMD1;RPL11;ASB4;AMBRA1;GPI;NLK;USP25;GABARAP;HSP90AB1;UBE2W;FANCL;STAM;PER1;RELA;CUL5;PA2G4;GLMN;MID1;UBE2A;TNK2;TRAF6;ATXN3;SUMO1;TRIB1;SMC6;TMBIM6;DTX1;USP7;SMAD5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4621530963456588,-1.0699315236147715,0.3874458874458874,0.8324594132529134,1.0,3/10,9.67%,PIK3CB;ATM;PIK3C2B
prerank,cation channel activity (GO:0005261),-0.27081309621975325,-1.0698165527867627,0.30522088353413657,0.8258845458568674,1.0,24/94,17.50%,CACNB2;SLC24A3;SLC24A2;TRPM3;TMEM38B;PIEZO1;CACNA1D;TRPC1;NALCN;SLC24A4;CACNA1E;TRPC3;KCNA1;KCNA2;PIEZO2;TRPC5;ANXA9;TMEM63C;SEC61A1;HVCN1;KCNK9;ABCC9;TMEM63A;SLC24A5
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4756631999039862,1.0678367293836213,0.362453531598513,0.7279008147279875,1.0,2/12,7.25%,RRH;GPR52
prerank,LRR domain binding (GO:0030275),-0.4102859818671764,-1.0674077543372502,0.3643724696356275,0.8259884149857945,1.0,4/14,19.69%,ROBO1;DDIT3;PAWR;ATF4
prerank,N-acyltransferase activity (GO:0016410),-0.33931782676220557,-1.066398308767577,0.36639118457300274,0.8221706749240717,1.0,10/32,20.08%,SAT1;TGM2;SMARCE1;SIRT7;CERS4;CERS5;CERS1;TLCD3B;NAA80;CERS2
prerank,ephrin receptor activity (GO:0005003),-0.39571058038781537,-1.0654652717086208,0.34834123222748814,0.8114976745941701,1.0,6/17,18.93%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.39571058038781537,-1.0654652717086208,0.34834123222748814,0.8114976745941701,1.0,6/17,18.93%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4634378571827286,1.0648641557354197,0.38786764705882354,0.7317229496053582,1.0,6/13,17.41%,ITGB1BP1;ARHGDIA;ARHGDIB;EIF5;RGS14;GDI2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.29535898289909257,-1.064566429971273,0.3475409836065574,0.8076059317266365,1.0,19/60,15.95%,MERTK;EPHA7;BMPR1B;ACVR1;FGFR2;FLT1;NTRK3;AXL;EPHB1;EPHA10;ALK;FLT3;CSF1R;ERBB4;EPHA3;TGFBR2;TYRO3;EPHB2;ACVR1B
prerank,tau protein binding (GO:0048156),0.3659466214237213,1.064463388086051,0.3554119547657512,0.7292908715589844,1.0,14/40,17.84%,APOE;GSK3B;ROCK1;ACTB;FYN;DYRK1A;PPP2CA;PPP2CB;MARK2;ROCK2;EP300;HSP90AB1;MARK3;PICALM
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.437081188328402,-1.0637980655266976,0.3869565217391304,0.8032830450301591,1.0,5/11,15.74%,CTC1;HNRNPA2B1;STN1;TERF2;HNRNPA1
prerank,protein kinase C activity (GO:0004697),-0.4136914698703763,-1.0625011593247873,0.39658848614072495,0.800479042934728,1.0,3/14,8.70%,PRKCD;PRKCE;CCL3
prerank,metalloexopeptidase activity (GO:0008235),0.3556266544226731,1.061440154836612,0.37464788732394366,0.7328272572048324,1.0,7/51,10.23%,PEPD;CPQ;XPNPEP3;LNPEP;ZMPSTE24;RNPEP;ENPEP
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.318403216028046,-1.0614048002566911,0.3608815426997245,0.7973225938927518,1.0,20/37,29.06%,FARSA;AARS1;CARS1;TARS2;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;NARS2;KARS1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3964701898093904,1.0599339928146452,0.3739565943238731,0.7331134788824722,1.0,4/28,7.31%,BABAM2;RIPK1;TNF;EDA
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.4612258817751654,-1.058937453528512,0.4029535864978903,0.7985401467493721,1.0,4/10,23.50%,NAA60;NAA25;NAA80;NAA30
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.32651788169234003,-1.0564490029923892,0.3839541547277937,0.7996513803710186,1.0,10/35,15.47%,AARS1;QTRT1;TRDMT1;TARS2;DUS1L;TRMT12;BCDIN3D;QTRT2;TRMT9B;MTFMT
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4312233534345564,1.0559750132237447,0.41818181818181815,0.738987155558678,1.0,4/19,5.21%,GAS6;ABI1;GHRL;PAK2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3505375344414964,-1.055462749850875,0.3753280839895013,0.7961942513530426,1.0,9/26,16.46%,SLC16A6;SLC16A3;MPC2;SLC16A1;ABCG2;SLC16A4;MPC1;SLC6A1;SLC16A9
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.45622003471527167,-1.0548914810511505,0.3969631236442516,0.7918014274930497,1.0,6/10,27.23%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,potassium channel regulator activity (GO:0015459),0.35865712402038513,1.054402575712346,0.39344262295081966,0.7393870874215671,1.0,14/49,19.14%,SGK3;RASA1;ADRB2;KCNAB2;KCNMB1;WNK1;ARPP19;YWHAE;KCNAB3;NEDD4L;KCNE3;SLC5A3;SUMO1;KCNIP1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3676355204868416,1.05302221568017,0.3901689708141321,0.7391569176515768,1.0,7/42,5.98%,PDLIM5;RAB10;S100A11;TMOD3;STXBP6;PDLIM1;ANXA2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28230551504527346,1.0516578167141781,0.35917901938426455,0.739072408804811,1.0,52/248,18.29%,GNAQ;RAP1B;ATP2B1;KIF20B;RAB31;RAP2B;ATL1;GBP3;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;VPS4B;GEM;RHOBTB1;GNB1;RAB7A;RAB14;RAB1A;RAB23;GNG5;CLPX;MYO1E;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;LSG1;GNA13;HBS1L;RAB32;ABCB10;TOR1B;RHOF;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3921256870038532,1.0504315778908357,0.40540540540540543,0.7388636396552413,1.0,7/27,13.63%,ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF19A
prerank,adrenergic receptor binding (GO:0031690),-0.4063068814139461,-1.0483686614469534,0.40232558139534885,0.804620408105256,1.0,6/16,7.67%,GNAS;MAGI2;DLG4;GRK2;UCHL1;APLP1
prerank,SUMO transferase activity (GO:0019789),0.4372021986598519,1.0481607333521556,0.39864864864864863,0.7409237866284377,1.0,4/16,8.74%,PIAS1;PIAS2;NSMCE2;MDM2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.43463187147007276,-1.0476430481749877,0.40941176470588236,0.8006242331849831,1.0,7/12,29.49%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,protein kinase regulator activity (GO:0019887),0.31825604362798093,1.0448330650028816,0.391304347826087,0.7457176522025095,1.0,20/95,14.55%,PRKAG2;SH3BP5;GMFG;DNAJC3;PRKAG3;RPLP1;RGCC;GPRC5B;WNK1;CCND3;CCNYL1;SMCR8;CCND2;CCNJ;MARK2;SH3BP5L;ELP4;CCNQ;CCNY;PARVA
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.38060602841920066,-1.0446619757360733,0.3927710843373494,0.803135717458722,1.0,5/18,21.34%,AKR1B1;ALDH18A1;ALDH1A1;ALDH1A2;AKR1B10
prerank,AMP binding (GO:0016208),-0.44375689509068256,-1.039497341963617,0.4,0.811912363676315,1.0,5/11,9.30%,MPPED2;PFKL;PRKAG1;PYGL;PFKP
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3964492279136291,1.0323136972800748,0.38144329896907214,0.7722823231841391,1.0,6/22,16.03%,MTMR3;DUSP12;DUSP1;DUSP2;DUSP23;DUSP7
prerank,mRNA methyltransferase activity (GO:0008174),0.4447046163704489,1.0297735873592335,0.3829787234042553,0.7748884756789072,1.0,6/12,23.11%,NSUN2;TRMT61B;CMTR2;TRMT61A;METTL16;PCIF1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4604630054134984,1.0284926618975443,0.4525939177101968,0.774480815835522,1.0,6/12,18.87%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2727918113499391,1.0280101338349479,0.4006514657980456,0.7722643504270685,1.0,72/346,16.08%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;UBE2E3;SIAH2;SEL1L2;CDC42;CBL;PELI1;RMND5A;PRKN;TRIM56;ZNRF3;BIRC3;RNF141;RC3H1;KLHL13;UBE2Q2;TRIM32;FBXL5;ANKIB1;MYCBP2;TRIM24;TRIM47;DTX2;BIRC6;TRIM68;SHPRH;TRIM27;RNF121;MDM2;RNF19B;UBE2K;UBE2D3;UHRF2;COP1;CUL3;MKRN1;RNF38;FBXO11;RNF14;ZNRF2;RNF111;AMFR;RNF185;UBE3B;TRIM71;CBLB;MIB1;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;ASB12;BFAR;BCOR;ANKRD39;NEDD4L;MKRN2;RNF122;ASB4;RNF41;FBXW2;TRIM25;UBE2W;FANCL
prerank,anion channel activity (GO:0005253),0.3332776738900629,1.0250644693476352,0.41640866873065013,0.7759610390579946,1.0,9/61,10.28%,CLCN5;ANO6;LRRC8D;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,protein phosphatase activator activity (GO:0072542),-0.40956533518219895,-1.024951217294361,0.45726495726495725,0.8475497372515725,1.0,6/13,21.06%,CALM2;PPP2R5C;PPP2R5A;PTPA;IGFBP3;CALM3
prerank,dynactin binding (GO:0034452),0.4467872343123659,1.024687794149755,0.43100189035916825,0.7734646331492466,1.0,5/12,14.51%,SNX6;GSK3B;SNX5;PAFAH1B1;SPTBN5
prerank,DNA replication origin binding (GO:0003688),0.3958559027138992,1.0235985921755681,0.4301948051948052,0.7729502735597897,1.0,6/23,15.90%,ORC5;ORC2;MCM9;DDX11;KAT7;MCM8
prerank,GABA receptor activity (GO:0016917),-0.3562418157425108,-1.0233976185487268,0.42748091603053434,0.8455035741878381,1.0,8/21,29.49%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,insulin-like growth factor I binding (GO:0031994),0.444824659252211,1.0230711899329281,0.44403669724770645,0.7708176412027296,1.0,2/13,4.97%,IGFBP4;INSR
prerank,sequence-specific mRNA binding (GO:1990825),-0.4493003242685172,-1.0208979257004025,0.44562899786780386,0.8463613771104226,1.0,4/10,18.92%,FMR1;SHFL;TYMS;DHX9
prerank,hormone activity (GO:0005179),0.34008730895814776,1.0206455901635032,0.3863298662704309,0.7732615549866819,1.0,8/54,14.26%,METRNL;C1QTNF12;GHRL;IGF1;CCK;METRN;NPPC;TRH
prerank,chloride channel regulator activity (GO:0017081),0.4384881588931284,1.017059841282322,0.41929499072356213,0.7784021911331829,1.0,3/14,8.48%,SGK3;WNK1;STX7
prerank,translation elongation factor activity (GO:0003746),0.44174504097393674,1.0169816358915107,0.44346289752650175,0.7752071873709535,1.0,2/14,3.68%,EEF1A1;EEFSEC
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35969772565620955,1.016349073897646,0.4413145539906103,0.7733071393814057,1.0,11/33,16.47%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3224159957675664,1.016248971889812,0.42547033285094066,0.7702280840385685,1.0,6/73,5.83%,EDNRB;CYSLTR1;CALCRL;NPR3;S1PR2;ADCYAP1R1
prerank,magnesium ion binding (GO:0000287),0.2977185441743515,1.0148938032497758,0.43112244897959184,0.7701381515213532,1.0,24/135,15.99%,NLRC4;MAP3K5;CDC42BPG;IRAK3;OXSR1;ERN1;MOV10L1;PDE2A;STK3;GEM;CLYBL;TKT;MAP3K20;MAST1;MARK2;FOXK2;STK38;PRKACB;DIS3L2;XYLT2;NUDT18;PAPOLA;NLK;IDH1
prerank,motor activity (GO:0003774),-0.28465888409154916,-1.0110407647681399,0.43333333333333335,0.8688188946003028,1.0,17/60,17.39%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;MYO6;CENPE;DYNC2H1;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.35859512995474996,-1.0108494467214832,0.45584725536992843,0.8633104363795202,1.0,6/21,12.13%,AKAP8L;AKAP6;AKAP7;ARFGEF1;AKAP8;WASF1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4304273113986399,1.0092159479708562,0.4473684210526316,0.7805534349666345,1.0,1/14,1.39%,BLVRB
prerank,omega peptidase activity (GO:0008242),-0.25701293527256674,-1.0077077180888703,0.4186991869918699,0.8665760851478955,1.0,22/89,14.82%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;GGT5;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;GGT7;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5
prerank,nucleotide diphosphatase activity (GO:0004551),-0.39580801202233173,-1.004694231919451,0.46271929824561403,0.8692097299401695,1.0,6/14,26.23%,ENPP5;NUDT6;FHIT;NUDT13;NUDT12;NUDT11
prerank,transition metal ion binding (GO:0046914),0.2665566278029668,1.0045892373024898,0.44155844155844154,0.7879924265676964,1.0,70/397,15.49%,GDA;ALOX5;RPS29;CRIP1;ALOX15;KMT2A;ANG;AGMO;ARIH1;GYG1;SORD;PHF8;LARGE2;ENDOU;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;AFM;MGAT2;XPNPEP3;GCH1;NQO2;MOXD1;FTL;KDM7A;GLO1;LNPEP;RC3H1;CRIP2;ACER3;ATP7A;FBXL5;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;AOX1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;FTH1;ETHE1;RASSF1;LACTB2;CBLB;KDM5C;LOXL2;SEC24D;SHMT1;TET2;MBD1;XYLT2;KAT6A;ARG2;PAPOLA;ZDHHC20;SAMHD1;MELTF;MYT1;HDAC4;KDM2A
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.3928803091188612,-1.003733333198573,0.4465811965811966,0.8659985848266413,1.0,3/12,8.06%,GNS;SULF1;ARSG
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4185335708437896,-1.0035101393650891,0.4613778705636743,0.8606543956807122,1.0,4/11,18.89%,SLC1A3;SLC1A1;SLC6A1;SLC1A2
prerank,chloride channel activity (GO:0005254),0.3267315530231359,1.0010597689938299,0.4479638009049774,0.7932322531006907,1.0,9/59,10.28%,CLCN5;ANO6;CLCNKB;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3338224633876725,1.0007534075230766,0.4421052631578947,0.7905925210173731,1.0,6/49,7.81%,MCTP1;CPNE2;CPNE7;ANXA2;CPNE8;MCTP2
prerank,mRNA binding (GO:0003729),-0.2226163107529066,-0.9999862831649867,0.436241610738255,0.8648342641151623,1.0,57/249,16.95%,DDX5;SNRNP70;SRRM2;LUC7L3;CPSF6;EIF4G1;ELAVL2;RBM25;NCL;RBFOX1;SRRM4;SRSF5;HNRNPA2B1;EIF4A1;FXR2;TARDBP;TP53;PKM;ZC3H12B;HNRNPU;ELAVL4;HNRNPLL;FUBP1;CPEB2;SECISBP2;RIDA;FMR1;PPIE;CELF4;RBMS3;KHDRBS3;CSTF2;RNPS1;CLUH;SHFL;UNK;TYMS;CIRBP;ADARB1;MYH10;UPF3B;NOVA2;C1QBP;UTP23;CARHSP1;QKI;SF3B1;NCBP1;N4BP1;PCBP1;SLC4A1AP;PCBP2;RBM5;SNIP1;PARK7;ANGEL2;PABPC4
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4186367302246634,-0.9987214117683886,0.4607218683651805,0.8625634191208831,1.0,4/11,23.89%,KCND2;KCNK2;KCNT1;KCND1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3689490151249558,0.9986390194358917,0.4323873121869783,0.7923102738359498,1.0,6/29,12.43%,SPRED1;PRKAG2;SFN;HSPB1;SPRED2;CDKN2C
prerank,ATPase binding (GO:0051117),0.3170282842819526,0.9973714995693798,0.44755244755244755,0.7919361786329318,1.0,19/71,15.71%,EGFR;PPP3CA;ESR1;S100A1;SNU13;ATP6V0A1;PDE4D;PEX26;VCPKMT;PSEN1;PLN;SNX10;WFS1;NR1H2;RALB;PKD2;USP25;NCSTN;NOP58
prerank,MHC class I protein binding (GO:0042288),0.4275159365019654,0.9969395971025945,0.46083788706739526,0.7897184240969601,1.0,1/13,2.73%,LILRB1
prerank,microtubule motor activity (GO:0003777),-0.28833954364992104,-0.9967732314129228,0.4447852760736196,0.8621557154264909,1.0,28/51,34.98%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;CENPE;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A;KIFC1;KIF14;KIF5B;KIFC3;KIF2C;KIF20A;DNAH3;KIF18B;KIF19;KIF9;KIF27;KIF24;KIF7
prerank,protein tyrosine kinase activity (GO:0004713),0.2968225124330542,0.995804646716727,0.4713541666666667,0.7892735614953387,1.0,18/108,11.81%,EGFR;FGFR1;PEAK1;LYN;FER;FRK;INSR;CAMKK2;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A;EPHB4;STYK1;SLA;JAK1
prerank,voltage-gated ion channel activity (GO:0005244),-0.396016345264648,-0.9954238247902346,0.4649122807017544,0.8601139545634608,1.0,5/14,14.04%,KCND2;CACNA1E;VDAC1;VDAC3;HVCN1
prerank,store-operated calcium channel activity (GO:0015279),-0.4340502492383093,-0.9951559195910266,0.48625792811839325,0.8551596570579897,1.0,5/10,12.31%,TRPC4;ORAI2;TRPC1;TRPC3;TRPC5
prerank,growth factor activity (GO:0008083),-0.2582174560241026,-0.9943316844486766,0.49514563106796117,0.8519230691852467,1.0,8/74,6.81%,TGFA;NRG3;CSF1;FGF2;VEGFB;CSPG5;OSGIN2;BDNF
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3667485174469238,0.9942860100025244,0.45032051282051283,0.7894936500452014,1.0,9/27,18.53%,POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;PRIM1;CRCP;POLR2F
prerank,myosin II binding (GO:0045159),-0.4296734318538099,-0.9942325343767164,0.4708333333333333,0.8466111440756756,1.0,4/10,15.89%,LLGL1;SHROOM1;SHROOM4;LLGL2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3182055494036111,-0.9920940113610558,0.4903581267217631,0.8468893321784859,1.0,15/29,43.32%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4;SLC25A21;SLC13A5;SLC46A1;ABCC2;SLC1A5;SLC26A3;SLC26A4;SLC25A18
prerank,snRNA binding (GO:0017069),-0.2877748447172165,-0.9911671407814866,0.46831955922865015,0.8437627765245398,1.0,7/42,8.31%,SNRNP70;CDK9;DDX39B;HNRNPU;CCNT2;SNRPA1;PRPF4
prerank,chemoattractant activity (GO:0042056),-0.332580218369997,-0.9887949894875931,0.4512820512820513,0.8444497676771855,1.0,13/26,39.69%,FGF2;VEGFB;CCL3;MIF;HMGB1;DEFB130A;CX3CL1;FGF7;BMP4;VEGFD;CXCL10;VEGFA;CCL15
prerank,hexosyltransferase activity (GO:0016758),0.28914543624608713,0.985398291171068,0.47774869109947643,0.8072827392834853,1.0,18/101,11.37%,EXT1;GBE1;GYG1;FUT4;LARGE2;UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1;B4GALT6;ALG9;POGLUT3;ALG5;POGLUT1;B4GALT5;B4GALNT3
prerank,regulatory RNA binding (GO:0061980),0.34566040086025424,0.9852027564720225,0.46904024767801855,0.8044344123260069,1.0,8/38,13.53%,TUT7;RC3H1;PUM2;RBM4;TUT4;TRIM71;ZC3H12A;PIWIL2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3288385913802077,0.9825228689264219,0.4822485207100592,0.8074054592055314,1.0,11/49,15.22%,PTPRJ;PTPN22;DUSP28;SMPDL3A;DUSP12;HDHD2;LHPP;PPP1CA;ACP3;DUSP23;SAMHD1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3123700277312656,0.982223112686441,0.4722222222222222,0.8048162036179056,1.0,10/71,7.38%,PTPRJ;PTPN18;PTPN20;PTPN12;PTPN22;MTMR3;DUSP1;PTPRK;PTPRA;DUSP22
prerank,R-SMAD binding (GO:0070412),-0.3520066341956183,-0.9777182966518734,0.4489795918367347,0.8683320437522828,1.0,2/18,0.37%,DDX5;LDLRAD4
prerank,Toll-like receptor binding (GO:0035325),0.44494565657234497,0.9761518647328545,0.5160075329566854,0.8156991841947753,1.0,2/11,4.23%,CD36;TLR2
prerank,poly-pyrimidine tract binding (GO:0008187),0.37791595302576136,0.9722886643002876,0.5204081632653061,0.8212964280833054,1.0,5/23,12.66%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,ion channel activity (GO:0005216),-0.25003540067510444,-0.9710662417903675,0.49382716049382713,0.8810313658327603,1.0,14/80,12.24%,GRID2;GRIA2;GRIK2;GRIA4;TRPM3;PIEZO1;GRIN3A;TMC7;GABRB1;TRPC1;NALCN;GRIN2A;PIEZO2;TMEM120B
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3572362433836402,-0.9699960991600539,0.47897196261682246,0.8783706067284383,1.0,4/16,23.81%,CLCN7;SLC1A1;CFTR;SLC12A5
prerank,ATP hydrolysis activity (GO:0140603),0.32741515446229047,0.9682539923191004,0.5054263565891473,0.8277140139854845,1.0,5/41,10.51%,ATP2B1;KIF20B;VPS4B;CLPX;MYO1E
prerank,cAMP binding (GO:0030552),0.43108045678530593,0.9680039576802738,0.490272373540856,0.8250697455004586,1.0,3/11,5.72%,RAPGEF2;PDE2A;PDE4D
prerank,adenyl ribonucleotide binding (GO:0032559),0.25926025237594263,0.9679134817733288,0.5363128491620112,0.8220366549502658,1.0,26/291,6.39%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;PRKAG3;ERN1;MOV10L1;HMGCR;RAPGEF2;PDE2A;CDK6;PNPLA8;INSR;ATP7A;PDE4D;STK3;WNK1;NOL9
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4053112690759694,0.9658997956788953,0.510752688172043,0.8235859841829446,1.0,1/14,3.24%,DHRS3
prerank,glycine binding (GO:0016594),-0.39926953078047156,-0.9651522348452454,0.5191489361702127,0.8858862569155288,1.0,5/11,22.80%,GRIN3A;GLRB;GLRA1;GLRA3;GLRA2
prerank,metalloendopeptidase activity (GO:0004222),0.30665995847602834,0.9629803351794445,0.49577464788732395,0.827140380949371,1.0,13/76,13.48%,ADAM19;ADAMTSL5;ADAM9;ADAMTS19;ZMPSTE24;PITRM1;ADAMTS18;ADAMTS10;ADAMTS9;MMP28;MMP24;MMP25;ADAMTS17
prerank,RNA polymerase binding (GO:0070063),-0.3497321296832595,-0.9610799607624635,0.5282167042889391,0.8909077612007471,1.0,7/18,13.01%,BIN1;PABPN1;CCNT2;TCERG1L;BRCA1;TCERG1;PHRF1
prerank,proton transmembrane transporter activity (GO:0015078),0.32971567305146526,0.9610743720322433,0.4892966360856269,0.8279662429512494,1.0,10/39,21.39%,CLCN5;ATP6V1B1;COX7A2L;COX10;SLC33A1;MFSD3;UQCRFS1;NDUFA4;CYB5A;COX5A
prerank,nucleotidyltransferase activity (GO:0016779),0.3878076420741179,0.9601747051645586,0.49206349206349204,0.8267879622521717,1.0,4/19,8.57%,TUT7;TENT2;TUT4;PAPSS2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3408470772833515,0.9595336265220448,0.5141955835962145,0.8249365391662974,1.0,11/33,16.47%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,zinc ion binding (GO:0008270),0.2592556756688633,0.9567959127998354,0.5503355704697986,0.8277964946736713,1.0,55/293,16.87%,GDA;RPS29;CRIP1;KMT2A;ARIH1;SORD;PHF8;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;AFM;GCH1;NQO2;KDM7A;GLO1;LNPEP;RC3H1;CRIP2;ACER3;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;RASSF1;LACTB2;CBLB;KDM5C;SEC24D;SHMT1;TET2;MBD1;KAT6A;ZDHHC20;SAMHD1;MYT1;HDAC4;KDM2A;CHORDC1;ERAP1;RABIF;GTF2B;TAB3;MSRB3
prerank,cholesterol binding (GO:0015485),-0.27283073795674007,-0.9564477940795727,0.5512048192771084,0.8977378300270354,1.0,9/47,14.78%,ABCG1;GRAMD1A;SCARB2;OSBPL6;STARD3;APOD;VDAC1;GRAMD1C;OSBPL2
prerank,sialyltransferase activity (GO:0008373),0.3830422131866669,0.9552621344762837,0.5114638447971781,0.8279451445939806,1.0,3/20,3.59%,ST8SIA4;ST6GAL1;ST3GAL1
prerank,poly-purine tract binding (GO:0070717),-0.3143191700509248,-0.9549864469965992,0.486284289276808,0.8961067175173403,1.0,10/27,16.95%,TIA1;HNRNPU;ELAVL4;FMR1;PPIE;HNRNPDL;RBMS3;MCRS1;DDX1;PABPC4
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.24560099246783493,-0.953181023217095,0.541501976284585,0.8954608902780775,1.0,22/83,17.18%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.36306758618804347,0.9513028362159072,0.5078260869565218,0.8338178514776237,1.0,5/22,12.43%,ZFP36L2;ZFP36L1;ILF3;ZC3H12A;EXOSC8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.39343461944917607,-0.9511150317948105,0.5237068965517241,0.8957318308078105,1.0,5/11,18.53%,UBE4A;RBX1;ANAPC11;PRPF19;STUB1
prerank,intracellular chloride channel activity (GO:0061778),0.40273247682919633,0.9506239349905822,0.5120593692022264,0.8290424620730126,1.0,3/16,6.15%,ANO6;ANO1;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.40273247682919633,0.9506239349905822,0.5120593692022264,0.8290424620730126,1.0,3/16,6.15%,ANO6;ANO1;TTYH3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.33092322256346846,0.95002967335025,0.5217391304347826,0.8272245770124959,1.0,7/42,11.84%,FBXW7;RASA1;CRK;SYK;ZAP70;SHC1;YWHAE
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.39016128856467136,-0.9500010449471528,0.5389473684210526,0.8932516960600402,1.0,4/11,8.68%,GNPTAB;PTDSS1;SAMD8;PTDSS2
prerank,insulin-like growth factor binding (GO:0005520),0.3976707562691801,0.9475737239869894,0.5158450704225352,0.8295461669390227,1.0,3/15,10.76%,IGFBP4;INSR;IGFALS
prerank,snoRNA binding (GO:0030515),-0.29916656630736294,-0.947482488816114,0.5374331550802139,0.8942747293772403,1.0,12/30,28.23%,XRCC5;NOP56;UTP6;NOP14;BMS1;GAR1;TSR1;NUDT1;BYSL;DHX37;NUDT16;NUDT5
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.3740794747054339,0.9456845143066903,0.5168350168350169,0.8306959034049873,1.0,4/21,17.25%,DRD1;CHRNA4;GRM1;CHRNB2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.3729827752784215,0.9450939334917746,0.5302245250431779,0.8288592874418117,1.0,2/21,4.00%,FGF23;FRS2
prerank,mRNA 3'-UTR binding (GO:0003730),0.2910764941436245,0.9441097122287344,0.5482954545454546,0.8279413271886329,1.0,16/79,13.22%,RBMS1;ZFP36L2;HNRNPC;ZFP36L1;RPL41;RC3H1;PUM2;RPL5;LARP4B;RBM4;RPS7;SERBP1;ILF3;ZC3H12A;EXOSC8;LARP4
prerank,O-acyltransferase activity (GO:0008374),-0.29971731535017054,-0.9409733441330969,0.556390977443609,0.9059590937614408,1.0,5/30,16.51%,LPCAT2;LPCAT1;LPCAT3;MBOAT7;AWAT2
prerank,peptidoglycan binding (GO:0042834),0.4333676501674554,0.9400378634999829,0.5298507462686567,0.8337484580321325,1.0,4/10,25.21%,TLR2;NOD2;RNASE7;NLRP3
prerank,vitamin D receptor binding (GO:0042809),0.38749979341120905,0.9383195580334923,0.5172413793103449,0.8344092302573897,1.0,10/14,27.88%,MED16;SNW1;MED17;THRAP3;MED14;MED24;MED13;TAF11;MED12;RXRA
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.31317813242745635,0.9365004779643314,0.5427286356821589,0.8355342433730488,1.0,8/49,10.47%,RNF169;EPS15;BABAM2;BRCC3;MINDY2;ZFAND2B;UBQLN4;ZRANB3
prerank,metallocarboxypeptidase activity (GO:0004181),0.3596139541815464,0.9346723407008924,0.5472636815920398,0.8366473890046632,1.0,1/26,0.62%,PEPD
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3091438310959014,-0.9343081551015238,0.5424164524421594,0.9185025165582783,1.0,6/26,14.99%,CHPF2;B3GALNT2;B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,calcium-release channel activity (GO:0015278),0.3780032944822193,0.9342640674174639,0.5044883303411131,0.8344317182560587,1.0,5/17,14.90%,TPCN1;TRPM2;MCOLN2;PKD2;ITPR3
prerank,poly(A) binding (GO:0008143),-0.32714711642140937,-0.9335119831030366,0.5446224256292906,0.9152970943082539,1.0,8/21,16.95%,TIA1;HNRNPU;ELAVL4;PPIE;HNRNPDL;RBMS3;DDX1;PABPC4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.35792753161270024,0.9319613648445372,0.5238879736408567,0.8364651556976141,1.0,8/24,18.83%,SESTD1;SNX3;GOLPH3L;OSBPL8;OSBPL5;GOLPH3;CERT1;ARFIP2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.35710933367505143,-0.931446708733749,0.5522041763341067,0.915155606561804,1.0,3/15,4.10%,HS3ST5;HS3ST4;HS6ST1
prerank,hormone receptor binding (GO:0051427),-0.3676053684387668,-0.9305102748829208,0.5482546201232033,0.9122493821282581,1.0,3/14,9.80%,JAK2;SOCS2;ADCYAP1
prerank,NADP binding (GO:0050661),0.3346630097539992,0.9282221580794505,0.5444444444444444,0.8417447546350427,1.0,8/32,20.58%,DPYD;HMGCR;GMDS;LBR;CBR3;DHCR7;DUS2;ME1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.2632241083443407,-0.9275388073324407,0.5833333333333334,0.9145405486590712,1.0,24/48,37.67%,SLC12A2;TRPM3;PIEZO1;TRPC1;NALCN;SLC12A6;PIEZO2;ABCC9;UNC80;SLC12A4;MMGT1;PKD1L3;SLC39A1;TRPM7;CALHM6;TRPV2;TRPM6;CALHM5;TRPC6;ATP6V1F;GRIN3B;TRPM1;ASIC3;SLC46A1
prerank,fibroblast growth factor binding (GO:0017134),0.3697696563383783,0.9272055843963366,0.5448504983388704,0.840824431562938,1.0,1/21,0.59%,FGFR1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.25621464207451833,-0.9261346937326657,0.5825825825825826,0.9126826706791813,1.0,8/56,7.69%,BLNK;NRG3;DOCK4;PITPNM1;TP53;ITGAX;PITPNM3;SHC3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3419741885149022,-0.9235318625503179,0.5399568034557235,0.9141597431892303,1.0,3/16,11.34%,SLC44A2;SLC25A26;SLC7A8
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.37330364632492113,-0.9228644890992745,0.5553191489361702,0.9106099211439115,1.0,8/12,40.26%,ENTPD6;CANT1;ENTPD3;NUDT5;ENTPD2;ENTPD5;NUDT15;SLC25A42
prerank,alkali metal ion binding (GO:0031420),-0.3656867580512468,-0.9220034026212215,0.567032967032967,0.9076121199846983,1.0,1/13,1.05%,CAPN3
prerank,ATP binding (GO:0005524),0.24835781262782392,0.9181841507334533,0.637911464245176,0.8569521445889015,1.0,33/266,12.23%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;ERN1;MOV10L1;CDK6;PNPLA8;INSR;ATP7A;STK3;WNK1;NOL9;ZAP70;MAP3K20;MAST1;PMVK;MTREX;CLPX;MARK2;HSPA13;STK36;STK38;PRKACB;MKNK1
prerank,ubiquitin binding (GO:0043130),-0.24755682181887795,-0.9176013718162616,0.674496644295302,0.9132917934989411,1.0,21/73,16.99%,MVB12B;OTULINL;BIRC2;FBXO7;AUP1;UCHL1;TOM1L1;RNF168;DNAJB2;SIRT2;NSFL1C;UBXN1;OTUB1;TOP2A;NPLOC4;USP5;N4BP1;ASCC2;USP33;GGA3;SQSTM1
prerank,nuclear receptor coactivator activity (GO:0030374),0.2993696831725117,0.9170486777479813,0.58887171561051,0.8563917965885088,1.0,22/52,22.62%,NCOA3;NCOA2;NCOA7;PRKCB;NCOA6;BUD31;DCAF6;SFR1;CNOT9;ENY2;USP22;ELK1;KDM1A;PPARGC1B;MED17;SS18;WDR77;THRAP3;MED14;ZMIZ1;ATXN7L3;MED24
prerank,single-stranded RNA binding (GO:0003727),0.3131438188668755,0.9153411108072265,0.5605839416058395,0.8570727739801667,1.0,10/43,14.37%,TLR8;DDX60;HNRNPF;DDX11;ILF3;EIF4B;LACTB2;RBM11;AQR;POLR2D
prerank,Hsp90 protein binding (GO:0051879),0.3327390440989079,0.9139609525971736,0.5682888540031397,0.8569071694177736,1.0,4/33,4.37%,AHR;RPS3;ERN1;NR3C1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2867407917592341,0.9120800172464099,0.5905292479108635,0.8579851663330366,1.0,8/70,3.64%,EXT1;LARGE2;UGT1A8;UGT1A6;UGT1A7;UGT1A4;UGT1A10;UGT1A1
prerank,glucose transmembrane transporter activity (GO:0005355),0.3779695164098401,0.9105347536556432,0.5616197183098591,0.8584521146155016,1.0,5/17,20.08%,SLC2A4;SLC2A2;SLC5A11;SLC5A3;SLC2A6
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3443976587919574,-0.9103633594669519,0.5995370370370371,0.9259907091427688,1.0,4/15,9.67%,PIK3CB;PI4KA;ATM;PIK3C2B
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.39264734363748666,0.908828993323707,0.5526315789473685,0.8589952412735796,1.0,2/11,14.90%,TRPM2;ITPR3
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3731298670467946,-0.9086230409803601,0.5938144329896907,0.9252356598040803,1.0,3/12,4.96%,GNAS;YWHAH;SOCS2
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3174795230884094,-0.9073237247338917,0.6091127098321343,0.9233446097146901,1.0,9/21,23.22%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,telomerase RNA binding (GO:0070034),0.3505009008445577,0.9072169153366141,0.5709515859766278,0.8593761460758726,1.0,5/22,16.18%,HNRNPC;SMG6;DCP2;PINX1;NOP10
prerank,sulfotransferase activity (GO:0008146),-0.28440630300854386,-0.906507159494168,0.6025974025974026,0.9202391657618942,1.0,6/33,10.83%,CHST11;CHST1;HS6ST1;TPST1;CHST2;GAL3ST4
prerank,deubiquitinase activity (GO:0101005),-0.23041455131872812,-0.9045042966731028,0.6680327868852459,0.9200400400697436,1.0,22/88,17.18%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;USP46;STAMBP;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3926768369440427,0.9041882624973185,0.5626168224299065,0.8630141426248163,1.0,4/12,16.36%,TENT5A;TENT2;PAPOLA;TUT1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3223981304568724,0.8972047082183734,0.610223642172524,0.8751237428016435,1.0,6/34,10.64%,IQGAP1;INCENP;STK3;FAM20A;PARP16;CALM1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3238415859423078,-0.8968632281938772,0.5860566448801743,0.9334015548052178,1.0,4/18,11.90%,SOCS2;SOCS7;AGAP2;PIK3R5
prerank,DNA polymerase activity (GO:0034061),-0.30854663313745395,-0.8961495943165608,0.6253041362530414,0.9298645334053423,1.0,9/22,23.22%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,protein phosphatase 1 binding (GO:0008157),0.354357117084137,0.895849073034461,0.5738831615120275,0.8749606155661995,1.0,6/21,15.54%,LILRB1;PPP1R3C;PPP1R3D;KCNQ1;AKAP11;PPP1R3B
prerank,copper ion binding (GO:0005507),0.3097214116547985,0.8952986062681738,0.5772727272727273,0.8730736623051275,1.0,6/42,6.21%,ANG;AOC1;MOXD1;ATP7A;ACR;PAM
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.24186624902373055,-0.8934059779792521,0.6302250803858521,0.9313175728891655,1.0,14/57,22.10%,CYB561A3;COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;NDUFA8;NDUFA10;UQCR10;NDUFS1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3266164767577786,-0.8925811216514372,0.6308068459657702,0.9283473515828269,1.0,2/20,1.14%,LPCAT2;LPCAT1
prerank,metallopeptidase activity (GO:0008237),0.2673896692584691,0.8923443056335583,0.6283870967741936,0.8763432026024021,1.0,20/113,15.95%,ADAM19;ADAMTSL5;ADAM9;LNPEP;ADAMTS19;ZMPSTE24;BRCC3;PITRM1;ADAMTS18;ADAMTS10;ADAM12;RNPEP;ADAMTS9;MMP28;MMP24;MMP25;ADAMTS17;EIF3H;MMP11;ERAP1
prerank,protein phosphatase 2A binding (GO:0051721),-0.30312017107482125,-0.890821530709719,0.6480582524271845,0.9276396786413823,1.0,7/23,14.65%,ADCY8;TP53;GRIN3A;MAPT;CTTNBP2NL;ANKLE2;STRN4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4160336520122049,0.890665810834396,0.6026615969581749,0.8770104839560255,1.0,4/10,19.04%,EHHADH;HADHA;HADHB;ECHDC1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3691274368329647,-0.8900036890933447,0.5887265135699373,0.9247316306885891,1.0,5/11,28.23%,DCPS;NUDT1;NUDT11;NUDT16;NUDT5
prerank,bHLH transcription factor binding (GO:0043425),0.35171253743969466,0.8880388890676979,0.5769881556683587,0.879457648347477,1.0,5/19,15.93%,TCF12;SP1;CREBBP;USF1;KDM1A
prerank,histone methyltransferase binding (GO:1990226),-0.3730854756893651,-0.8875399778517659,0.6433260393873085,0.9258360339617793,1.0,2/11,2.48%,CTNNB1;NOP56
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3997257972011157,0.882927153476701,0.59375,0.8872365215371404,1.0,2/11,17.25%,CHRNA4;CHRNB2
prerank,death receptor binding (GO:0005123),0.3759704792165336,0.8795163705937609,0.5951134380453752,0.8911206694060646,1.0,2/15,7.31%,RIPK1;EDA
prerank,anion:anion antiporter activity (GO:0015301),0.3654693567966778,0.877978599462919,0.6026490066225165,0.8913161485780741,1.0,7/17,26.83%,SLC26A11;SLC25A5;SLC26A7;SLC25A4;SLC26A8;SLC25A11;SLC26A2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.38493281692507936,0.8778489583413055,0.5875706214689266,0.888553309075944,1.0,4/12,18.57%,BABAM2;TNF;TRAP1;TRAF6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.26801200455728524,-0.8773491315463958,0.6604774535809018,0.9397867469131461,1.0,9/34,22.10%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.26801200455728524,-0.8773491315463958,0.6604774535809018,0.9397867469131461,1.0,9/34,22.10%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3365990643901794,0.8770130697484634,0.6174957118353345,0.8843313751576902,1.0,6/21,13.42%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3365990643901794,0.8770130697484634,0.6174957118353345,0.8843313751576902,1.0,6/21,13.42%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,GABA receptor binding (GO:0050811),0.4055867524274914,0.8760392654539244,0.5943396226415094,0.8833656220584821,1.0,6/11,23.31%,PLCL2;TRAK2;GABARAP;JAKMIP1;TRAK1;ARFGEF2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.289660807850157,-0.8760146364291325,0.65,0.9378680138316945,1.0,6/26,20.23%,MGAT5;PPP1R11;PPP1R14A;SAG;PABIR1;CABIN1
prerank,endopeptidase activity (GO:0004175),0.24003815367875755,0.8745350519630224,0.735527809307605,0.8834725662836918,1.0,42/257,15.93%,CTSC;ADAM19;PSMA7;ADAMTSL5;ADAM9;RHBDD1;USP9X;CTSB;PARL;RHBDF1;ACR;HTRA3;ADAMTS19;ZMPSTE24;PITRM1;PREP;ADAMTS18;USP15;PSMB2;PSEN1;ADAMTS10;TPP2;ADAMTS9;USP16;SFRP1;F10;CASP8;USP24;PSMA6;USP14;KLK9;MMP28;MMP24;MMP25;ADAMTS17;USP9Y;PSMA3;USP28;SENP1;USP25;USP47;MMP11
prerank,kinesin binding (GO:0019894),-0.2924806332787148,-0.8742559680798481,0.6460396039603961,0.9368541169609339,1.0,6/27,14.52%,PLEKHM2;NEFH;IFT88;CROCC;NEK6;AP1AR
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.33737153168777256,0.8741672312073316,0.6029900332225914,0.8753828422441667,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,serotonin receptor activity (GO:0099589),0.33737153168777256,0.8741672312073316,0.6029900332225914,0.8753828422441667,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.33737153168777256,0.8741672312073316,0.6029900332225914,0.8753828422441667,1.0,3/22,12.60%,HRH1;HTR1D;HTR6
prerank,carboxylic ester hydrolase activity (GO:0052689),0.26851440761771617,0.8737464842305942,0.6450276243093923,0.8733716672025855,1.0,14/85,17.50%,AOAH;PGAP1;PLA2G7;NOTUM;PLA2G2D;PLAAT1;ACHE;LYPLAL1;PLAAT3;NDST3;PAFAH1B2;LYPLA1;ESD;CEL
prerank,semaphorin receptor binding (GO:0030215),-0.30696817508641766,-0.8726069785395053,0.6344647519582245,0.9357866441731896,1.0,10/23,27.83%,SEMA4D;SEMA4C;SEMA4G;SH3BP1;PLXNB1;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,estrogen receptor binding (GO:0030331),0.3168536168122593,0.8722584366156275,0.6288,0.8733971367689808,1.0,9/32,16.40%,ESR1;ARID5A;WIPI1;NRIP1;NCOA6;LCOR;STRN;MMS19;PPARGC1B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3332707131773798,0.871050585424741,0.6206896551724138,0.8729030145104406,1.0,6/24,19.35%,IP6K3;PMVK;CMPK1;AK8;AK3;AK4
prerank,neurexin family protein binding (GO:0042043),-0.3734429666795588,-0.8698543584916542,0.6333333333333333,0.9372250408367332,1.0,3/10,17.31%,NLGN1;SYTL2;CPE
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3629902809480754,0.8693757894402319,0.6247723132969034,0.8733197425862415,1.0,2/15,5.18%,SESTD1;SNX3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3924607192861011,0.8693381385276941,0.6149312377210217,0.8705483179421931,1.0,3/10,19.43%,DCLRE1C;MGME1;APEX1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.28728357196787563,-0.8666274608881516,0.6693333333333333,0.9397736681927209,1.0,2/28,1.93%,GRID2;GRIK2
prerank,translation initiation factor activity (GO:0003743),-0.2610554605787473,-0.8654892808125084,0.6739130434782609,0.9375569065586169,1.0,6/36,7.06%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D;EIF3B
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3328644624991276,0.8630234488810192,0.6070175438596491,0.879850727358539,1.0,3/24,5.27%,DAPK1;CAMK1D;MAPKAPK2
prerank,phospholipase activator activity (GO:0016004),-0.37245816470912585,-0.8595180498935491,0.6365461847389559,0.9460640746673287,1.0,4/10,11.81%,SRC;BTK;CCL3;PDPK1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3495113411668639,-0.8572977991512193,0.6466512702078522,0.9461006963302753,1.0,3/12,9.67%,PIK3CB;ATM;PIK3C2B
prerank,phospholipase binding (GO:0043274),-0.3455841562071386,-0.8563234287649871,0.6438923395445134,0.9434093926505996,1.0,4/13,11.81%,BLNK;SRC;BTK;PDPK1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3950259337786434,0.856282073450596,0.6305970149253731,0.887149186345992,1.0,3/10,16.03%,DUSP1;DUSP2;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3950259337786434,0.856282073450596,0.6305970149253731,0.887149186345992,1.0,3/10,16.03%,DUSP1;DUSP2;DUSP7
prerank,pyrophosphatase activity (GO:0016462),0.2862879317443593,0.8556796550697516,0.6396946564885496,0.8855418257912507,1.0,8/50,11.37%,BNIPL;PRUNE2;NUDT22;RNGTT;DOLPP1;LHPP;TRPM2;DCP2
prerank,acetyltransferase activity (GO:0016407),0.30891994982849014,0.854978667435101,0.6496124031007752,0.8841171602355345,1.0,9/31,16.47%,ESCO2;ESCO1;CREBBP;SAT2;EP300;KAT6A;ACAT1;PAFAH1B2;GTF2B
prerank,MAP kinase activity (GO:0004707),-0.33800793910967697,-0.8547772442989893,0.6577777777777778,0.9419962900679213,1.0,3/14,6.30%,MAPK10;MAPK6;MAPK3
prerank,RNA stem-loop binding (GO:0035613),0.3867092181656499,0.853240227233183,0.6539855072463768,0.8846699543324762,1.0,8/12,25.32%,RC3H1;ZC3H12A;CSDE1;METTL16;EPRS1;CPEB3;LARP6;RC3H2
prerank,metalloaminopeptidase activity (GO:0070006),0.3652128236016777,0.8513778962331553,0.631578947368421,0.8855431276409009,1.0,4/16,10.23%,XPNPEP3;LNPEP;RNPEP;ENPEP
prerank,glycerophospholipid flippase activity (GO:0140333),-0.3551221603583409,-0.8512775932151708,0.655011655011655,0.9447940541033107,1.0,2/11,5.58%,ATP8A2;ATP8B1
prerank,ATPase activator activity (GO:0001671),0.34421897970973664,0.84593870400406,0.6677471636952999,0.8929830636612047,1.0,5/20,17.10%,FXYD2;DNAJC1;AHSA1;MYBPC3;DNAJC15
prerank,lipid phosphatase activity (GO:0042577),0.36622687495210604,0.8407010646203025,0.65625,0.9000602507138422,1.0,1/14,1.59%,SGPP1
prerank,MAP kinase phosphatase activity (GO:0033549),0.3711315628454341,0.839989540941204,0.6477064220183486,0.8986369363830052,1.0,3/12,16.03%,DUSP1;DUSP2;DUSP7
prerank,potassium ion antiporter activity (GO:0022821),0.351975883696929,0.8395433815293558,0.6583969465648855,0.8965890722607224,1.0,4/15,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.32040087997267414,0.8377055195815629,0.6807432432432432,0.8973836049756364,1.0,3/25,3.97%,PARP14;PARP8;PARP11
prerank,methyl-CpG binding (GO:0008327),-0.2929848500929051,-0.8369365919043124,0.6982543640897756,0.9698730212677654,1.0,4/22,13.00%,CXXC5;ZCWPW1;LRWD1;ZBTB33
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.30011971113412744,0.8352437712675708,0.712171052631579,0.8990105239345282,1.0,10/31,18.08%,UBE2E3;UBE2Q2;BIRC6;UBE2K;UBE2D3;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.313188356801614,-0.8345236960178486,0.6765327695560254,0.9703349689748759,1.0,7/15,34.86%,SOCS2;SOCS7;PIK3R5;PIK3R2;PIK3R3;SOCS3;SOCS1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3337652390972955,0.8331313220702835,0.6529209621993127,0.9002221206131902,1.0,2/20,1.34%,CASK;MPP1
prerank,ribosomal large subunit binding (GO:0043023),0.38694922689152544,0.8328283715568816,0.6785046728971963,0.8979578831269609,1.0,4/11,12.04%,NMD3;MRRF;MALSU1;DHX33
prerank,gamma-tubulin binding (GO:0043015),0.3269023110048388,0.8302606706896678,0.650709219858156,0.8998464567992442,1.0,1/21,0.52%,RAB11FIP5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.33594462577720763,-0.829904508165002,0.6864406779661016,0.9754378569911399,1.0,5/12,28.77%,CNOT7;PAN2;TOE1;PNLDC1;NOCT
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.29251158349737605,0.8293782298635514,0.7051282051282052,0.8986990353016379,1.0,10/34,18.08%,UBE2E3;UBE2Q2;BIRC6;UBE2K;UBE2D3;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,endopeptidase regulator activity (GO:0061135),0.2892467304830687,0.8289884634508398,0.700626959247649,0.8966860609075114,1.0,7/40,18.50%,NLRC4;PROS1;USP14;CAST;SERPIND1;TFPI;RENBP
prerank,sodium channel activity (GO:0005272),-0.2549641783418695,-0.8283213959454183,0.7520891364902507,0.9739236745821751,1.0,5/37,14.31%,GRIK2;SCN1B;SHROOM2;SCN8A;SCN1A
prerank,protein phosphatase regulator activity (GO:0019888),-0.2312266612930573,-0.8272372309318703,0.8151515151515152,0.9713689927016059,1.0,14/53,21.06%,MGAT5;CALM2;PPP1R16B;PPP2R2B;PPP1R7;PPP2R5C;ANKLE2;SAG;PPP6R1;PPP1R16A;PPP2R5A;PTPA;CABIN1;CALM3
prerank,glutamate receptor binding (GO:0035254),0.33961487432715054,0.8267503031773628,0.6759581881533101,0.8977032182747448,1.0,1/17,0.32%,HIP1
prerank,ATPase regulator activity (GO:0060590),0.29139151993882295,0.8265529937532866,0.7040358744394619,0.8953676620468446,1.0,6/38,10.15%,FXYD2;BAG3;FNIP1;DNAJC1;PLN;AHSA1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30791606137672145,0.8264432132247358,0.6816720257234726,0.892876401962273,1.0,5/27,14.66%,ATP2B1;TMEM165;ATP2B4;SLC23A1;CNNM4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2821018226949905,0.8257595433048041,0.7168674698795181,0.8913901054642471,1.0,10/44,15.25%,KMT2A;SETDB2;ASH2L;KMT2C;WDR82;KMT5B;SMYD3;KMT2E;EHMT1;NSD3
prerank,calcium activated cation channel activity (GO:0005227),0.34119454807086375,0.8254447895570293,0.6649395509499136,0.8892638272937354,1.0,3/17,5.28%,ANO6;KCNMB1;ANO1
prerank,lipase activator activity (GO:0060229),-0.3613924590399062,-0.8238475520095985,0.7022132796780685,0.9732779765521277,1.0,4/10,11.81%,SRC;BTK;CCL3;PDPK1
prerank,amino acid binding (GO:0016597),-0.259368306697516,-0.8235502976016806,0.7604456824512534,0.9691907115080928,1.0,14/31,26.95%,GRM7;AARS1;GRIN3A;GLRB;CASTOR2;GLRA1;GLRA3;DDAH1;AARS2;GLRA2;AGXT;CAD;CASTOR1;GCLC
prerank,syntaxin binding (GO:0019905),-0.22756722761584838,-0.8235289491725872,0.8269230769230769,0.9646395969220514,1.0,21/61,27.26%,UNC13C;SNAP25;SNAP47;VPS18;STX16;CPLX1;NAPA;SYT6;VAMP2;SYT8;SYT1;GOLGA2;CPLX2;BAIAP3;ABCA1;NAPG;VAMP1;VPS11;SYT5;STXBP1;SYT17
prerank,hydro-lyase activity (GO:0016836),0.28613578113542076,0.8233772823398472,0.7145015105740181,0.8902200906123716,1.0,12/41,21.63%,HACD4;EHHADH;GMDS;ACO1;HADHA;HADHB;UROS;FAHD2A;ECHDC1;CDYL;IREB2;PCBD2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22687959666385385,-0.8231795078133729,0.8126888217522659,0.9607301301992434,1.0,8/53,12.85%,SLC1A3;SLC36A1;SLC38A7;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.31144866858013026,0.8223457543730466,0.6965944272445821,0.8892854281445733,1.0,6/27,16.38%,ANO1;SLC26A11;SLC26A7;XPR1;SLC25A30;GET3
prerank,nuclear import signal receptor activity (GO:0061608),0.34388960946354963,0.8220502654707547,0.6756272401433692,0.8871112078602782,1.0,7/15,24.22%,KPNA4;KPNA2;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,3'-5' exonuclease activity (GO:0008408),-0.2324233699300825,-0.8219441726233161,0.7833333333333333,0.9586494864488825,1.0,16/45,32.86%,CNOT7;EXOSC9;DIS3;POLG;PAN2;REV3L;ANGEL2;TOE1;RAD50;ERI3;PNLDC1;RAD9A;ANGEL1;NOCT;RAD1;PNPT1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3522545419685198,0.8215064911237243,0.6755793226381461,0.8854301877762786,1.0,2/13,11.27%,EHHADH;SREBF2
prerank,phosphatase activator activity (GO:0019211),0.3434324133077455,0.8199041206476515,0.6955719557195572,0.8856216483363663,1.0,6/14,21.26%,BMP2;FRS2;CALM1;PPP2R5B;PHACTR4;PPP2R5E
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.33977280723881126,0.8167557726836943,0.6842105263157895,0.8885798587943965,1.0,5/17,19.35%,NOL9;CMPK1;AK8;AK3;AK4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3207092058258354,0.8162252378686438,0.6821192052980133,0.8867788612178746,1.0,4/25,11.44%,FMO1;CYP27A1;CYP26B1;FMO5
prerank,neuropeptide receptor binding (GO:0071855),-0.3248343080422136,-0.8152271706071879,0.7447306791569087,0.9671777750520918,1.0,6/14,50.04%,SHANK1;NPY;APLN;GAL;NPPA;GHRH
prerank,FAD binding (GO:0071949),0.3120919658185456,0.8141959005974846,0.6996753246753247,0.8877400319312398,1.0,3/24,6.59%,DAO;NQO2;AGPS
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2679003833311033,0.8137084133621557,0.7533834586466165,0.8860156015212394,1.0,15/55,17.39%,ATP2B1;MCU;ANXA2;PSEN1;PKD1L2;TRPV3;TMEM165;TRPM2;ATP2B4;ATP2A2;PKD2L1;PKD2;PANX1;PKD2L2;CUL5
prerank,transforming growth factor beta binding (GO:0050431),0.3196007437712286,0.8107027485677551,0.6971235194585449,0.8887336361426084,1.0,3/23,8.25%,NRROS;CD36;VASN
prerank,ankyrin binding (GO:0030506),-0.2885340990308194,-0.8100714138179278,0.7546296296296297,0.9724242387916819,1.0,4/19,15.65%,SLC8A1;CACNA1D;SPTB;KCTD6
prerank,platelet-derived growth factor binding (GO:0048407),-0.34202314307236575,-0.8094737911698493,0.7130620985010707,0.9690375675671432,1.0,7/11,30.09%,COL1A2;PDGFA;COL3A1;COL6A1;PDGFRB;COL4A1;COL5A1
prerank,NADPH binding (GO:0070402),0.35245913818135743,0.8073021443900952,0.6934579439252336,0.8919490704663819,1.0,4/13,20.39%,HMGCR;LBR;CBR3;DUS2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.34392894605879243,-0.8070306256078915,0.7330508474576272,0.9690128707433326,1.0,2/11,12.35%,SLC2A9;SLC17A5
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.36252858806357174,0.8063821571711126,0.7049808429118773,0.8909508985306268,1.0,1/11,1.97%,RPS3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3510222381442286,0.8062494936332277,0.6798561151079137,0.8885900158602573,1.0,3/12,11.24%,FRS2;SH2B3;SHC1
prerank,hexose transmembrane transporter activity (GO:0015149),0.36229306168437925,0.8037184337362284,0.7126654064272212,0.8901886907845783,1.0,4/12,20.08%,SLC2A4;SLC2A2;SLC5A3;SLC2A6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.25142331660052714,0.8035217956076538,0.7503486750348675,0.8878777186250288,1.0,12/74,12.24%,POMK;ADK;PGM2L1;NOL9;FAM20A;CHKB;PIK3C2A;PAPSS2;FGGY;DGKH;PANK1;GALK2
prerank,carboxylic acid binding (GO:0031406),-0.2436078319793757,-0.8031173759267553,0.8131868131868132,0.9716501561763896,1.0,11/38,16.82%,GRM7;UBR1;PHYH;GRIN3A;SESN3;GLRB;CASTOR2;MAG;GLRA1;PSAP;GLRA3
prerank,sulfate transmembrane transporter activity (GO:0015116),0.3540351113369369,0.8010843307204968,0.7132743362831858,0.8894720377019957,1.0,6/14,26.83%,SLC26A11;SLC26A7;SLC25A30;SLC26A8;SLC25A11;SLC26A2
prerank,methylated histone binding (GO:0035064),-0.21680464092412283,-0.7998610323987609,0.8410596026490066,0.9729527188181469,1.0,26/62,33.03%,BPTF;ING4;ZCWPW1;WDR5;FMR1;DPF2;LRWD1;KDM4A;CBX5;PHF2;PHF1;PHF13;MTF2;TAF1;CXXC1;TTLL12;UHRF1;CBX8;MPHOSPH8;THAP7;MSH6;TAF7;RRP8;MSL3;ING5;PHF19
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3123212779916526,-0.797787077128276,0.753880266075388,0.9721116864213126,1.0,5/13,30.55%,SLC38A7;SLC3A1;SLC7A6;SLC25A29;SLC7A3
prerank,ligand-gated cation channel activity (GO:0099094),-0.20910622786853855,-0.7950199040221264,0.8876404494382022,0.972586323642828,1.0,31/75,37.28%,PTK2B;KCNJ2;GRIA2;GRIK2;GRIA4;GRIN3A;SHROOM2;GRIN2A;KCNN2;KCNK6;KCNJ3;ASIC1;KCNJ10;KCNJ13;GRIA3;KCNJ9;KCNH2;GRIA1;KCNJ12;KCNJ16;KCNN1;KCNJ6;P2RX3;P2RX5;GRIN3B;CHRNA7;ASIC3;SCNN1A;CHRNA5;ASIC4;KCNJ15
prerank,myosin binding (GO:0017022),0.26079109559335795,0.7938348765917697,0.7781155015197568,0.8991934277383663,1.0,12/55,16.07%,SPATA6;RAB10;RHOA;TRIM32;STXBP5;CXCR4;RAB14;KIRREL1;TRAK2;RAB11A;MYBPC3;RAB3B
prerank,CARD domain binding (GO:0050700),0.34222322807837713,0.7927289647284887,0.7209302325581395,0.898503574311071,1.0,4/14,12.73%,BCL10;CARD16;RIPK2;NOD2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.30973502658376534,-0.7884495685587872,0.7392241379310345,0.979618713699668,1.0,5/13,25.86%,DNA2;ENDOV;SLX4;DNASE1L2;EXO1
prerank,tRNA binding (GO:0000049),-0.2288284703865941,-0.7875874165598523,0.8613569321533924,0.9766887659954561,1.0,23/43,36.21%,AARS1;DALRD3;CARS1;PTCD1;TRNT1;SARS1;DARS2;ALKBH8;TRMT9B;PUS1;HSD17B10;AARS2;TRMT10B;SARS2;THG1L;ALKBH1;KARS1;NEMF;SSB;AIMP1;NSUN6;YRDC;EIF2A
prerank,lysine N-methyltransferase activity (GO:0016278),-0.27771791094643716,-0.787505919833351,0.7842227378190255,0.9724853850650517,1.0,10/20,36.47%,EHMT2;SETD4;SETD3;EEF2KMT;SETD2;SETD6;SMYD2;EEF1AKMT2;METTL21A;SETD7
prerank,ribosomal small subunit binding (GO:0043024),0.3283539078653422,0.7856733321106184,0.7428571428571429,0.9075297183256703,1.0,7/17,22.30%,ERAL1;EIF1;EIF4B;MTIF3;PIM1;DHX29;NPM1
prerank,ion gated channel activity (GO:0022839),0.29788808281954177,0.7780222953866708,0.7449664429530202,0.9171972172269085,1.0,3/24,6.15%,ANO6;ANO1;TTYH3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3267831849377545,-0.7778309388907056,0.7381489841986456,0.984308546546952,1.0,3/11,15.56%,PPP1R11;PPP1R14A;PABIR1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.3036913088702463,-0.7773301342400548,0.7829977628635347,0.9806147253038497,1.0,7/14,25.00%,NFU1;NUBPL;ISCU;SDHB;RSAD2;NDUFS1;ACO2
prerank,N-acetyltransferase activity (GO:0008080),-0.2836885150155819,-0.7746191252790484,0.7764127764127764,0.980530734484001,1.0,2/19,4.52%,SAT1;SMARCE1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.2975722674445357,-0.7746153562419107,0.7857142857142857,0.9762157758598556,1.0,10/14,47.56%,KCNJ2;KCNJ3;KCNH2;KCNIP2;KCNE4;KCNJ5;KCND3;KCNA5;KCNJ8;KCNE2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.33784116310272316,-0.7727022369058387,0.7543478260869565,0.9751212286663011,1.0,3/10,11.07%,NAA40;NAA60;BRCA2
prerank,cAMP response element binding (GO:0035497),-0.3358715744424402,-0.7725719295714594,0.75,0.9710529059460439,1.0,3/10,11.67%,E4F1;CREB3L2;JUN
prerank,ligand-gated calcium channel activity (GO:0099604),0.3005225005641483,0.7695475888459149,0.7753001715265866,0.9280606002185958,1.0,4/19,18.96%,GRIN2D;TRPM2;ITPR3;P2RX4
prerank,5'-nucleotidase activity (GO:0008253),0.3482514241868146,0.7693988316112632,0.7495145631067961,0.9256768814055449,1.0,3/13,14.75%,NT5DC1;NT5C2;ACP3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3329910726928127,0.765723863534388,0.7401129943502824,0.9286340286811324,1.0,2/14,7.18%,RARRES1;BST2
prerank,SUMO binding (GO:0032183),-0.31111562602839155,-0.7649230591801858,0.7935034802784223,0.9785143680100812,1.0,1/13,0.40%,HERC2
prerank,nuclear localization sequence binding (GO:0008139),0.3076368302658685,0.7583207797862551,0.7689594356261023,0.9373978452828441,1.0,8/18,24.22%,KPNA4;KPNA2;NUP153;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,Hsp70 protein binding (GO:0030544),0.27835627709240945,0.7566045949347303,0.8062992125984252,0.9371952247173299,1.0,3/31,4.00%,RPS3;ERN1;PRKN
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.32680779399238263,-0.7538379695621752,0.7926078028747433,0.9908000743078039,1.0,5/10,20.93%,B3GALT1;B3GALT5;B3GALT2;B4GALT7;B3GALT6
prerank,beta-tubulin binding (GO:0048487),-0.24241414876622353,-0.7533629329709247,0.8575342465753425,0.9871584915703898,1.0,7/31,19.70%,TBCD;FGF13;TTLL7;APPL1;GABARAPL1;EMD;BBS4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.32972628540735366,0.7521649852169516,0.7486437613019892,0.9411389545710674,1.0,4/12,16.61%,CDK12;CDK6;CDK13;BRD4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.30822511157231725,-0.7518369688867043,0.7987152034261242,0.9850319968917223,1.0,6/12,28.25%,STAT1;TBPL1;HDAC1;TAF1;TBP;FOS
prerank,phosphotyrosine residue binding (GO:0001784),0.2647042000599503,0.7514111665113288,0.7914691943127962,0.9395847337582427,1.0,5/37,11.24%,RASA1;CRK;SYK;ZAP70;SHC1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.23964335516326707,0.7492038632629159,0.8581267217630854,0.9399732014293448,1.0,15/69,17.82%,MOGAT2;ZDHHC14;ESCO2;ESCO1;ZDHHC3;CERS6;PLAAT1;CREBBP;EP300;KAT6A;PLAAT3;ZDHHC20;ZDHHC2;GTF2B;DGAT1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.2963492592320449,-0.7486044076340966,0.8148148148148148,0.985524765245281,1.0,8/12,28.85%,ISCU;SDHB;FXN;ISCA1;FDX1;CIAPIN1;CISD3;CISD1
prerank,sterol binding (GO:0032934),0.24524607616974714,0.74828149124632,0.8454810495626822,0.9387604949776823,1.0,11/56,16.57%,OSBPL9;STARD3NL;ERLIN1;OSBPL11;OSBPL1A;NPC2;GRAMD1B;OSBPL8;OSBPL10;OSBPL5;GPR183
prerank,carboxypeptidase activity (GO:0004180),0.2656327796030935,0.7368491380450158,0.8386075949367089,0.9521935860397235,1.0,1/35,0.62%,PEPD
prerank,U6 snRNA binding (GO:0017070),0.3119986910355888,0.7362594079945022,0.781021897810219,0.9503333981173911,1.0,4/14,16.36%,LARP7;LSM4;LSM2;TUT1
prerank,leak channel activity (GO:0022840),-0.270623920288575,-0.7340516249169544,0.8689655172413793,1.0,1.0,8/18,28.69%,NALCN;KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,nuclear export signal receptor activity (GO:0005049),-0.31315972066303177,-0.7323248751423915,0.7941176470588235,0.9994631757644549,1.0,5/11,36.04%,RANBP17;CSE1L;NUP214;EIF4ENIF1;RAN
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.31525699877759056,-0.728099748838192,0.843956043956044,1.0,1.0,5/10,29.49%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2943654853185834,-0.7277782341388841,0.8304347826086956,0.9970489242075011,1.0,2/13,4.67%,PRKAR1A;PRKAR1B
prerank,nucleotidase activity (GO:0008252),0.3166755943627022,0.7264040707712189,0.8176691729323309,0.9612505993015567,1.0,3/15,14.75%,NT5DC1;NT5C2;ACP3
prerank,ADP binding (GO:0043531),0.2767216301781186,0.725000915866503,0.8361204013377926,0.9605260566373465,1.0,2/25,3.17%,PRKAG2;ERN1
prerank,phosphatase activity (GO:0016791),0.22611214244771644,0.7179626641505021,0.8932038834951457,0.966933096006231,1.0,11/73,15.12%,PTPRJ;PTPN22;DUSP28;DUSP12;OCRL;HDHD2;LHPP;PPP1CA;ACP3;PTPMT1;DUSP23
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2580894680311166,-0.7166043802049188,0.8525,1.0,1.0,7/20,31.65%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,myosin V binding (GO:0031489),-0.2718760813157176,-0.7162852774946176,0.8367346938775511,1.0,1.0,2/15,4.42%,RAB6B;RAB3C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.2813062890499223,-0.7127734008466419,0.8581235697940504,1.0,1.0,5/13,20.44%,PIK3CB;PIK3C2B;PIP4K2B;PIP4K2C;PIP5K1B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.274406577720087,0.7114915457869232,0.8525121555915721,0.9725950247521541,1.0,5/24,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,histone acetyltransferase binding (GO:0035035),0.27090891719799687,0.7077078220721181,0.8449744463373083,0.9744826283961656,1.0,6/21,17.18%,MEF2A;TRIM68;KANSL1;BCAS3;KANSL1L;ZBTB7A
prerank,neuropeptide hormone activity (GO:0005184),-0.2481849553798397,-0.7039183387464485,0.883419689119171,1.0,1.0,14/22,50.32%,ADCYAP1;PENK;PNOC;GRP;NPFF;NPY;CRH;GAL;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,potassium ion leak channel activity (GO:0022841),-0.2722872428166202,-0.7036846213790492,0.8617511520737328,1.0,1.0,7/15,28.69%,KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,kinase activity (GO:0016301),0.20729502793941784,0.7002889453195651,0.9434210526315789,0.980658038474603,1.0,11/109,10.04%,POMK;LYN;PGM2L1;IP6K3;GSK3B;PKN2;CHKB;PIK3C2A;PAPSS2;PMVK;DGKH
prerank,serine-type endopeptidase activity (GO:0004252),-0.1800532054009062,-0.6985799596871068,0.9790940766550522,1.0,1.0,6/80,8.61%,KLK2;MASP1;HTRA2;PLAU;F3;RHBDL3
prerank,MHC class II protein complex binding (GO:0023026),-0.29697620433701744,-0.6984734438175318,0.8716814159292036,1.0,1.0,2/11,4.53%,ATP1B1;PKM
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.21935291369238605,-0.6961240422202151,0.9346049046321526,1.0,1.0,13/34,31.34%,EHMT2;SETD4;DOT1L;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;EZH2;TTLL12;PRDM9;SMYD2;EEF1AKMT2
prerank,exoribonuclease activity (GO:0004532),-0.28837905364330435,-0.6961115225932185,0.8766519823788547,0.9971665658597835,1.0,2/12,8.16%,CNOT7;EXOSC9
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2034886730045052,0.695825265408879,0.9484029484029484,0.9832070588575202,1.0,23/134,17.60%,SLC16A7;CD36;SLC25A17;SLC38A6;SLC25A24;SLC25A2;ABCC4;ABCC1;RTBDN;SLCO5A1;SLC35B3;SLC38A1;SLC2A2;SLC38A2;GJA1;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC6A6;SLC5A6;SLCO2A1;SLC36A2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.21546353524666165,-0.6940172898420326,0.9402173913043478,0.9954538987477579,1.0,10/33,28.77%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;ERI3;PNLDC1;ANGEL1;NOCT
prerank,fatty acid synthase activity (GO:0004312),-0.29562595082351883,-0.6930479621291071,0.8432203389830508,0.9924247045564286,1.0,7/10,36.82%,OXSM;ELOVL1;ELOVL4;ELOVL7;CBR4;ELOVL6;ELOVL2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2919138081196349,0.6917688298366078,0.8427787934186471,0.9850585078761906,1.0,1/15,6.84%,PLA2G2D
prerank,NF-kappaB binding (GO:0051059),0.2616312809584905,0.6909136910764199,0.8544839255499154,0.9833952614335586,1.0,8/24,22.30%,BCL10;GSK3B;PSMA6;EP300;RELA;BRMS1;FAF1;NPM1
prerank,DNA polymerase binding (GO:0070182),0.2791258719352847,0.689958835318761,0.8399311531841652,0.981804243560138,1.0,7/18,20.20%,SMG6;POLG2;HSP90AB1;FANCI;LONP1;RTEL1;PCNA
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2373615135828711,0.6890227736905785,0.8967136150234741,0.9803348197759298,1.0,8/38,15.42%,AXIN1;FRS2;SAV1;SH2B3;NUP62;SHC1;MMS19;RGS14
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.22018131333791136,-0.6867704519351328,0.9119170984455959,0.9948686514097976,1.0,11/30,31.65%,SLC40A1;TTYH1;SLC39A11;SLC11A2;SLC39A13;SLC39A14;ATP7B;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,syntaxin-1 binding (GO:0017075),-0.23569528695738012,-0.6858513814894055,0.9084158415841584,0.9918205617638359,1.0,6/22,19.42%,UNC13C;SNAP25;CPLX1;VAMP2;SYT1;CPLX2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2410709958024255,0.6857599154135001,0.8890728476821192,0.9812381337729121,1.0,8/35,16.92%,FOXP1;NR3C1;KLF10;H3-3A;GTF2A1;MYC;GTF2B;RELA
prerank,aminopeptidase activity (GO:0004177),0.26220399756704427,0.6837945018568649,0.8629032258064516,0.9807037152698959,1.0,4/26,10.23%,XPNPEP3;LNPEP;RNPEP;ENPEP
prerank,cardiolipin binding (GO:1901612),0.3119764802871428,0.6822713965768225,0.8374760994263862,0.9796427612014157,1.0,2/10,16.37%,GSDME;UQCC3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.22555906200047682,-0.6806215500548594,0.8963963963963963,0.9931507681119509,1.0,11/28,27.84%,ENDOV;RPP14;POP1;RNASEH1;RPP21;EDC3;PRORP;POP7;EXO1;NUDT16;DBR1
prerank,ribonuclease P activity (GO:0004526),-0.2871688480017955,-0.6803370741185921,0.8677354709418837,0.9894871212632639,1.0,5/11,24.68%,RPP14;POP1;RPP21;PRORP;POP7
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.20888458207988533,-0.6795440896863745,0.9560439560439561,0.9862965299863407,1.0,10/34,28.77%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;ERI3;PNLDC1;ANGEL1;NOCT
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.2967784384294983,0.6736012464912996,0.8359073359073359,0.9862548333679448,1.0,1/13,2.60%,BMP2
prerank,receptor antagonist activity (GO:0048019),-0.2495334448526983,-0.6734324860747342,0.8871331828442438,0.987811359832756,1.0,3/17,19.28%,DKK2;IL18BP;DKK3
prerank,NAD+ binding (GO:0070403),-0.274040444523427,-0.6710955367175909,0.8716814159292036,0.985849106359279,1.0,4/12,18.39%,SIRT2;UXS1;SIRT5;PARP9
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2666978690370811,-0.6697947995470577,0.872651356993737,0.9831328267673879,1.0,5/14,24.68%,RPP14;POP1;RPP21;PRORP;POP7
prerank,four-way junction DNA binding (GO:0000400),-0.24954885081541234,-0.6651115162253226,0.9051918735891648,0.9833624386429197,1.0,7/17,31.90%,BLM;RAD51C;MSH2;HMGB1;HMGB3;MSH6;XRCC2
prerank,Notch binding (GO:0005112),0.25651682419413563,0.6612832655384314,0.889261744966443,0.9955970079928629,1.0,5/22,20.84%,JAG1;CUL3;SNW1;DTX1;ADAM17
prerank,BMP receptor binding (GO:0070700),0.2967800699632145,0.6599535857712283,0.849609375,0.9942101428518814,1.0,1/12,2.60%,BMP2
prerank,cytochrome-c oxidase activity (GO:0004129),0.27847812279332906,0.6592887282287924,0.8625678119349005,0.992219067831339,1.0,5/15,21.39%,COX7A2L;COX10;NDUFA4;CYB5A;COX5A
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.25639497037623993,0.6588022240780199,0.8743801652892562,0.990073768249205,1.0,3/22,10.47%,RNF169;MINDY2;ZRANB3
prerank,CoA hydrolase activity (GO:0016289),-0.2511526075650703,-0.6584478505319562,0.8966292134831461,0.9847772761429685,1.0,5/16,25.43%,ACOT9;ACOT7;ACOT11;ACOT8;ACOT1
prerank,phospholipase inhibitor activity (GO:0004859),-0.2827459438620644,-0.6557227546146907,0.8724696356275303,0.9832112126043133,1.0,3/10,18.04%,APOC1;ANXA9;ANGPTL3
prerank,chloride channel inhibitor activity (GO:0019869),0.3022092172413159,0.6521766124799361,0.8549905838041432,0.9936456017890662,1.0,2/10,8.48%,WNK1;STX7
prerank,thioesterase binding (GO:0031996),0.2910995531697775,0.6521420660811694,0.8636363636363636,0.9910572354156504,1.0,1/11,3.32%,CDC42
prerank,nucleosomal DNA binding (GO:0031492),-0.23026165067268461,-0.6519629397518378,0.9046454767726161,0.9824582821740491,1.0,13/21,35.05%,SMARCB1;SMARCC2;SMARCE1;RCC1;HDAC1;CHD4;MBD3;MBD2;SMARCD2;SMARCA4;HDAC2;HMGA2;MTA2
prerank,exonuclease activity (GO:0004527),0.21814480483931556,0.65003392026785,0.951734539969834,0.9903948373841395,1.0,13/46,22.11%,DCLRE1C;REXO2;CPSF3;ZC3H12A;EXOSC8;EXOSC1;DXO;ENPP1;APEX1;MRE11;REXO5;TRIR;EXOSC3
prerank,methylation-dependent protein binding (GO:0140034),-0.17979367727196643,-0.6496780364239712,0.9904458598726115,0.9803954610393972,1.0,22/57,33.03%,BPTF;ING4;ZCWPW1;WDR5;FMR1;LRWD1;KDM4A;CBX5;PHF2;PHF1;PHF13;MTF2;CXXC1;UHRF1;CBX8;MPHOSPH8;THAP7;MSH6;RRP8;MSL3;ING5;PHF19
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23824874658828016,0.6467941187740739,0.9124203821656051,0.9904769764876702,1.0,6/32,15.49%,PHF8;KDM7A;TET3;HSPBAP1;TET2;KDM2A
prerank,peptide hormone receptor binding (GO:0051428),-0.2718970090641497,-0.6433798461129313,0.8966942148760331,0.9813041451189938,1.0,5/11,39.96%,ADCYAP1;PSMC5;PTHLH;GNRH1;VIP
prerank,acetylation-dependent protein binding (GO:0140033),0.25579032572545507,0.6424073170368846,0.8890784982935154,0.9890413419894974,1.0,3/20,11.15%,KMT2A;TRIM24;PHIP
prerank,lysine-acetylated histone binding (GO:0070577),0.25579032572545507,0.6424073170368846,0.8890784982935154,0.9890413419894974,1.0,3/20,11.15%,KMT2A;TRIM24;PHIP
prerank,exopeptidase activity (GO:0008238),0.2146632186022023,0.6406732517698919,0.9483500717360115,0.9878603400962173,1.0,7/50,10.23%,XPNPEP3;LNPEP;PRCP;ZMPSTE24;RNPEP;DPEP2;ENPEP
prerank,serine-type peptidase activity (GO:0008236),0.1929541488341106,0.6366023105169066,0.9718120805369127,0.9886387642625741,1.0,7/96,6.74%,ENDOU;RHBDD1;PARL;RHBDF1;ACR;HTRA3;PREP
prerank,single-stranded DNA binding (GO:0003697),0.1903904900697405,0.6309596951101346,0.9787234042553191,0.9905444670784074,1.0,18/93,18.45%,RBMS1;RBBP8;FAM111A;MCM9;DDX11;RPA1;RAD52;PURA;RPA3;XPC;POLR2D;RAD51B;SAMHD1;FBH1;MCM8;DMC1;APTX;LONP1
prerank,peptidase inhibitor activity (GO:0030414),0.22705601911115403,0.6289453849046842,0.9323899371069182,0.9896219542951373,1.0,7/33,18.50%,PROS1;USP14;CAST;SERPIND1;GPC3;TFPI;RENBP
prerank,signal sequence binding (GO:0005048),-0.1908871018947269,-0.6284688578465293,0.9821428571428571,0.988052059104513,1.0,2/35,2.28%,PEX5L;IPO5
prerank,steroid hydroxylase activity (GO:0008395),-0.23635122245455498,-0.6251887006958613,0.928416485900217,0.9863078793189901,1.0,8/16,42.75%,CH25H;CYP2A6;CYP39A1;CYP1A1;CYP46A1;CYP1B1;CYP2R1;CYP2S1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.22095714561785507,0.6198418846210759,0.9284603421461898,0.993846418318174,1.0,6/32,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,phosphatase inhibitor activity (GO:0019212),-0.21893347429279633,-0.6176499734471351,0.9471153846153846,0.987125716133309,1.0,3/20,20.23%,MGAT5;SAG;CABIN1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2544766630313874,-0.6136246421842717,0.926829268292683,0.9856461910966117,1.0,3/12,14.77%,NDUFS7;CRYZL1;AIFM2
prerank,histone methyltransferase activity (GO:0042054),-0.1963106463962464,-0.6124616887014623,0.9625668449197861,0.9825477688180982,1.0,11/32,29.87%,EHMT2;DOT1L;PRMT2;CARM1;SMYD1;SETD2;EZH2;TTLL12;PRDM9;SMYD2;PRMT8
prerank,ribosome binding (GO:0043022),0.20343673509479923,0.6099725355622829,0.9733124018838305,0.997782394134751,1.0,9/46,17.88%,RPSA;RACK1;SERBP1;SRP68;ZC3H12A;ETF1;MTIF3;PYM1;EFL1
prerank,methyltransferase activity (GO:0008168),-0.17362332921513063,-0.6070734042376731,0.9894736842105263,0.981673470613533,1.0,22/46,41.63%,COMT;AS3MT;FTSJ3;MEPCE;DNMT1;BCDIN3D;MRM2;LCMT1;METTL3;ASMT;RRP8;METTL27;PRMT8;GCSH;EEF1AKMT2;LRTOMT;FTSJ1;PRMT7;GAMT;MGMT;DNMT3B;EEF1AKMT4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.20430213531736297,0.6050570591184663,0.9748520710059172,0.998473411957912,1.0,10/55,17.60%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC6A11;SLC6A6;SLC36A2
prerank,alpha-tubulin binding (GO:0043014),0.22024724758363592,0.6042333279396865,0.9494949494949495,0.9964232160865066,1.0,9/31,22.12%,ARL8A;EFHC1;FYN;TBCE;TBCEL;SNCA;EFHC2;RACGAP1;DLEC1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.2653207240277006,0.5990021261511116,0.9109090909090909,0.9973072861573933,1.0,1/12,5.11%,RACK1
prerank,active ion transmembrane transporter activity (GO:0022853),0.20502871908182083,0.5891481980628371,0.9706336939721792,1.0,1.0,9/37,21.39%,SLC16A7;COX7A2L;SLCO5A1;COX10;UQCRFS1;SLCO2A1;NDUFA4;CYB5A;COX5A
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.18172820506773069,-0.5879893674416383,0.98989898989899,0.9871582602202102,1.0,5/32,13.81%,KCNQ3;KCNQ5;KCNA1;KCNA2;KCNS3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.20387038517842904,0.5875915385131435,0.9711246200607903,0.9987787857330653,1.0,8/42,15.79%,CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;CCNQ;CCNY;HEXIM2
prerank,palmitoyltransferase activity (GO:0016409),0.21977953444057163,0.5866530617410453,0.9713831478537361,0.9967115709377349,1.0,5/28,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23894480344985383,0.5858526308988813,0.9410681399631676,0.99464736526848,1.0,2/18,9.82%,HSD3B7;HSD17B7
prerank,NAD binding (GO:0051287),0.2172866322915624,0.5829522537627239,0.9603448275862069,0.9937156546471677,1.0,4/26,12.93%,SORD;CRYL1;HADH;GLUD1
prerank,solute:anion antiporter activity (GO:0140323),0.25375658462139034,0.5805038248639225,0.9318568994889267,0.992488627570731,1.0,3/14,21.84%,SLC26A11;SLC26A7;SLC26A8
prerank,aspartic-type endopeptidase activity (GO:0004190),0.25666719033312846,0.5716361974045435,0.9247706422018349,0.99452260454888,1.0,3/12,16.47%,PSEN1;SPPL2B;SPPL2A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.24302752266623456,0.5706389645636534,0.9385964912280702,0.9925449845490717,1.0,2/14,11.58%,RACK1;EBAG9
prerank,gap junction channel activity (GO:0005243),-0.19893658624935723,-0.5678206288671614,0.9818181818181818,0.9915636252156756,1.0,4/22,19.87%,GJB1;GJC1;GJD3;GJC2
prerank,ribonuclease P RNA binding (GO:0033204),-0.24213589027228738,-0.5581076264575826,0.9601593625498008,0.9913356114065148,1.0,4/10,24.68%,RPP14;POP1;RPP21;POP7
prerank,cation transmembrane transporter activity (GO:0008324),0.1883018607242525,0.5566130112535809,0.9924812030075187,0.9961276304411806,1.0,8/48,17.60%,SLC38A6;SLC25A2;SLC38A1;SLC8B1;SLC38A2;PKD2L1;SLC6A6;SLC36A2
prerank,pseudouridine synthase activity (GO:0009982),0.24005508877413514,0.5510409820512684,0.9523809523809523,0.995768793336616,1.0,1/13,5.12%,RPUSD3
prerank,acetylcholine receptor activity (GO:0015464),-0.18979713102497558,-0.5459900345525364,0.9926289926289926,0.991321601731377,1.0,10/22,48.95%,CHRM3;ANXA9;CHRFAM7A;CHRNA7;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,galactosyltransferase activity (GO:0008378),0.24181610281565713,0.5392443979897498,0.9536178107606679,0.9976734867933618,1.0,2/11,10.90%,B4GALT6;B4GALT5
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.23801325496546213,0.5381799333337182,0.96,0.9955970334864969,1.0,3/14,19.35%,CMPK1;AK8;AK4
prerank,N-methyltransferase activity (GO:0008170),0.21282271496381083,0.530903348438178,0.9734513274336283,0.9955705087349219,1.0,4/20,15.14%,TRMO;GNMT;PRMT1;HNMT
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.20936656412831942,-0.5172393048977216,0.9753363228699552,0.9943601850350755,1.0,13/13,79.09%,METTL1;TRMT10B;THUMPD3;FTSJ1;TRMT10C;TRMT5;TRMT11;TRMT1;TRMT10A;THUMPD2;TARBP1;TRMT1L;WDR4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.18255414559112002,-0.5171715627145838,0.9828431372549019,0.9907480939142318,1.0,3/22,14.31%,SCN1B;SCN8A;SCN1A
prerank,amino acid transmembrane transporter activity (GO:0015171),0.16942844994102607,0.5007166233697793,0.993920972644377,1.0,1.0,7/47,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,wide pore channel activity (GO:0022829),0.18971040894528574,0.4872627476375771,0.9858407079646018,1.0,1.0,23/23,81.06%,GJB2;GJA1;PANX1;GJB6;GJB5;GJB4;GJC3;GJE1;GJA9;GJA10;GJA8;GJD4;GJA3;PANX3;GJA4;GJA5;PRF1;GJD2;PANX2;GJC2;GJD3;GJC1;GJB1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.21950913313665188,0.4819281721672697,0.9754716981132076,1.0,1.0,11/11,78.06%,SLC25A47;SLC25A20;SLC22A5;SLC22A16;SLC6A20;SLC22A1;SLC25A48;SLC25A45;SLC22A3;SLC25A29;SLC22A4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.19489571555552904,-0.4711125330025156,0.9852631578947368,0.9947043512830321,1.0,3/11,20.04%,PRMT2;CARM1;PRMT9
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.20726884690226613,0.4531035892326363,0.994140625,1.0,1.0,11/11,79.29%,KCNQ1;KCNE3;KCNE5;KCNE1;KCNE2;KCNJ8;KCND3;KCNJ5;KCNE4;KCNH2;KCNJ3
prerank,adenyl nucleotide binding (GO:0030554),0.19900921202361865,0.4420805299742871,0.9980988593155894,0.9980431222879548,1.0,1/11,6.84%,BAG3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.19900921202361865,0.4420805299742871,0.9980988593155894,0.9980431222879548,1.0,1/11,6.84%,BAG3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.1715954040308907,0.4035441805040521,0.9932885906040269,0.9983269159169208,1.0,15/15,82.86%,SLC26A7;SLC26A8;SLC26A2;SLC26A6;SLC26A5;SLC26A1;SLC26A9;SLC39A8;SLC4A8;SLC4A11;SLC26A4;SLC4A1;SLC26A3;SLC4A3;CFTR
